Form 10-Q - Quarterly report [Sections 13 or 15(d)]

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2024

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from _______ to _______

Commission file number: 001-40932

CYNGN INC.

(Exact name of registrant as specified in its charter)

Delaware		46-2007094
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

1015 O’Brien Dr.
Menlo Park, CA 94025

(Address of principal executive offices) (Zip Code)

(650) 924-5905

(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:

Title of each class		Trading Symbol(s)		Name of each exchange on which registered
Common stock, $0.00001		CYN		Nasdaq Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	☐	Accelerated filer	☐
Non-accelerated filer	☒	Smaller reporting company	☒
		Emerging growth company	☒

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒

As of May 8, 2024, the issuer had 141,542,715 shares of common stock, par value $0.00001 per share, outstanding.

CYNGN INC.

TABLE OF CONTENTS

		Page No.
PART I FINANCIAL INFORMATION		1
ITEM 1.	FINANCIAL STATEMENTS	1
	Condensed Consolidated Balance Sheets as of March 31, 2024 (unaudited) and December 31, 2023	1
	Condensed Consolidated Statements of Operations for the Three Months ended March 31, 2024 and 2023 (unaudited)	2
	Condensed Consolidated Statements of Stockholders’ Equity for the Three Months ended March 31, 2024 and 2023 (unaudited)	3
	Condensed Consolidated Statements of Cash Flows for the Three Months ended March 31, 2024 and 2023 (unaudited)	4
	Notes to Condensed Consolidated Financial Statements (unaudited)	5
ITEM 2.	MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS	24
ITEM 3.	QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK	30
ITEM 4.	CONTROLS AND PROCEDURES	30
PART II OTHER INFORMATION		31
ITEM 1.	LEGAL PROCEEDINGS	31
ITEM 1A.	RISK FACTORS	31
ITEM 2.	UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS	31
ITEM 3.	DEFAULTS UPON SENIOR SECURITIES	31
ITEM 4.	MINE SAFETY DISCLOSURES	31
ITEM 5.	OTHER INFORMATION	31
ITEM 6.	EXHIBITS	31
SIGNATURES		32

PART 1 — FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS

CYNGN INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

	(Unaudited)
	March 31,			December 31,
	2024			2023

Assets
Current assets
Cash	$	2,192,398		$	3,591,623
Short-term investments		2,578,882			4,561,928
Prepaid expenses and other current assets		1,502,115			1,316,426
Total current assets		6,273,395			9,469,977

Property and equipment, net		1,652,382			1,486,672
Right of use asset, net		821,144			992,292
Intangible assets, net		1,045,412			1,084,415
Total Assets	$	9,792,333		$	13,033,356

Liabilities and Stockholders’ Equity
Current liabilities
Accounts payable	$	248,677		$	196,963
Accrued expenses and other current liabilities		720,239			1,201,142
Current operating lease liability		724,654			682,718
Total current liabilities	$	1,693,570			2,080,823

Non-current operating lease liability		127,572			317,344
Total liabilities	$	1,821,142			2,398,167

Commitments and contingencies (Note 12)
Stockholders’ Equity
Preferred stock, Par $0.00001, 10 million shares authorized; no shares issued and outstanding as of March 31, 2024 and December 31, 2023		-			-
Common stock, Par $0.00001; 200,000,000 shares authorized, 88,454,654 and 64,773,756 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively		884			648
Additional paid-in capital		173,958,005			170,652,160
Accumulated deficit		(165,987,698	)		(160,017,619	)
Total stockholders’ equity		7,971,191			10,635,189
Total Liabilities and Stockholders’ Equity	$	9,792,333		$	13,033,356

See accompanying notes to condensed consolidated financial statements.

CYNGN INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

	Three Months Ended March 31,
	2024			2023

Revenue	$	5,513		$	872,800
Costs and expenses
Cost of revenue		113,776			616,694
Research and development		3,154,695			3,030,056
General and administrative		2,703,401			3,070,920
Total costs and expenses		5,971,872			6,717,670

Loss from operations		(5,966,359	)		(5,844,870	)

Other income, net
Interest income		1,327			46,902
Other income (expense), net		(5,047	)		169,210
Total other income (expense), net		(3,720	)		216,112

Net loss	$	(5,970,079	)	$	(5,628,758	)

Net loss per share attributable to common stockholders, basic and diluted	$	(0.08	)	$	(0.15	)

Weighted-average shares used in computing net loss per share attributable to common stockholders, basic and diluted		77,081,105			37,685,413

See accompanying notes to condensed consolidated financial statements.

CYNGN INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

(Unaudited)

	Preferred Stock				Common Stock				Additional Paid-in		Accumulated			Total Stockholders’
	Shares		Amount		Shares		Amount		Capital		Deficit			Equity
Balance as of December 31, 2022		-		-		33,684,864	$	337	$	159,847,229	$	(135,730,039	)	$	24,117,527
Exercise of stock options and vesting of restricted stock units		-		-		34,728		-		6,844		-			6,844
Stock-based compensation		-				-				924,898		-			924,898

Net loss		-				-				-		(5,628,758	)		(5,628,758	)
Balance as of March 31, 2023		-	$	-		33,719,592	$	337	$	160,778,972	$	(141,358,797	)	$	19,420,512

	Preferred Stock				Common Stock				Additional Paid-in			Accumulated			Total Stockholders’
	Shares		Amount		Shares		Amount		Capital			Deficit			Equity
Balance as of December 31, 2023		-		-		64,773,756	$	648	$	170,652,160		$	(160,017,619	)	$	10,635,189
Exercise of stock options and vesting of restricted stock units		-		-		12,228		-		-			-			-
Stock-based compensation		-		-		-				654,024			-			654,024
Issuance of common stock at-the-market equity financing, net of offering costs of $54,137		-		-		13,302,681		133		2,651,977			-			2,652,110
Issuance of common stock for pre-funded warrants in connection with the private placement offering, net of offering costs of $156		-		-		10,365,989		103		(156	)		-			(53	)

Net loss		-				-				-			(5,970,079	)		(5,970,079	)
Balance as of March 31, 2024		-	$	-		88,454,654	$	884	$	173,958,005		$	(165,987,698	)	$	7,971,191

See accompanying notes to condensed consolidated financial statements.

CYNGN INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

	Three Months Ended March 31,
	2024			2023
Cash flows from operating activities
Net loss	$	(5,970,079	)	$	(5,628,758	)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization		225,590			228,031
Stock-based compensation		654,024			924,898
Realized gain on short-term investments		(39,938	)		(169,209	)
Gain on asset		52,723			-
Changes in operating assets and liabilities:
Prepaid expenses, operating lease right-of-use assets, and other current assets		(185,689	)		(258,859	)
Accounts payable		51,714			287,656
Accrued expenses, lease liabilities, and other current liabilities		(628,739	)		(761,207	)
Net cash used in operating activities		(5,840,394	)		(5,377,448	)

Cash flows from investing activities
Purchase of property and equipment		(214,238	)		(447,739	)
Acquisition of intangible asset		(19,634	)		(44,745	)
Purchase of short-term investments		(1,787,016	)		(10,497,206	)
Proceeds from maturity of short-term investments		3,810,000			13,742,000
Net cash provided by investing activities		1,789,112			2,752,310

Cash flows from financing activities
Proceeds from at-the-market equity financing, net of issuance costs	$	2,652,110		$	-
Issuance costs from public issuance of common stock and pre-funded warrants		(53	)		-
Proceeds from exercise of stock options		-			6,844
Net cash provided by financing activities		2,652,057			6,844

Net decrease in cash		(1,399,225	)		(2,618,294	)
Cash, beginning of period		3,591,623			10,586,273
Cash, end of period	$	2,192,398		$	7,967,979

Supplemental disclosure of cash flow:
Cash paid during the period for interest and taxes	$	-		$	-

Supplemental disclosure of non-cash activities:
Acquisition of property and equipment included in accounts payable and accrued expenses	$	27,552		$	139,568

See accompanying notes to condensed consolidated financial statements.

CYNGN INC. AND SUBSIDIARIES

Notes to Condensed Consolidated Financial Statements

(Unaudited)

1. Description of Business

Cyngn Inc., together with its subsidiaries (collectively, “Cyngn” or the “Company”), was incorporated in Delaware in 2013. The wholly owned subsidiaries are Cyngn Singapore PTE. LTD., a Singaporean limited company organized in 2015 and Cyngn Philippines, Inc., a Philippine corporation incorporated in 2018 and dissolved as of December 31, 2023. The Company is headquartered in Menlo Park, CA.

Cyngn develops and deploys scalable, differentiated autonomous vehicle technology for industrial organizations. Our full-stack autonomous driving software (“DriveMod”) can be integrated onto vehicles manufactured by Original Equipment Manufacturers (“OEM”) either via retrofit of existing vehicles or by integration directly into vehicle assembly. The Enterprise Autonomy Suite (“EAS”) is designed to be compatible with sensors and components from leading hardware technology providers and integrate our proprietary Autonomous Vehicle (“AV”) software to produce differentiated autonomous vehicles.

The Company has been operating autonomous vehicles in production environments and in 2023 began licensing EAS commercially. Built and tested in difficult and diverse real-world environments, DriveMod, the fleet management system and our proprietary Software Development Kit (“DriveMod Kit”) combine to create a full-stack advanced autonomy solution designed to be modular, extendable, and safe. The Company operates in one business segment.

Liquidity and Going Concern

The Company has incurred losses from operations since inception. The Company incurred net losses of approximately $6.0 million and $5.6 million for the three months ended March 31, 2024 and 2023, respectively. Accumulated deficit amounted to approximately $166.0 million and $160.0 million as of March 31, 2024 and December 31, 2023, respectively. Net cash used in operating activities was $5.8 million and $5.4 million for the three months ended March 31, 2024 and 2023, respectively.

The Company’s liquidity is based on its ability to increase its operating cash flow position, obtain capital financing from equity interest investors and borrow money to fund its general operations, research and development activities, and capital expenditures. The Company’s ability to continue as a going concern is dependent on management’s ability to successfully execute its business plan, which includes increasing revenue while controlling operating costs and expenses and obtaining funds from outside sources to generate positive financing cash flows. As of March 31, 2024, the Company’s unrestricted cash balance was $2.2 million, and its short-term investments balance was $2.6 million. As of December 31, 2023, the Company’s unrestricted cash balance was $3.6 million, and its short-term investments balance was $4.6 million.

Based on cash flow projections from operating, investing and financing activities and the existing balance of cash and short-term investments, management is of the opinion that the Company has insufficient funds for sustainable operations, and it may not be able to meet its payment obligations from operations and related commitments, if the Company is not able to complete the required funding transactions to allow the Company to continue as a going concern. Based on these factors, the Company has substantial doubt that it will continue as a going concern for the 12 months following the date these financial statements were issued. These condensed consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets and liabilities that may result in the Company not being able to continue as a going concern.

The Company’s plan to alleviate the going concern issue is to increase revenue while controlling operating costs and expenses and obtaining funds from outside sources of financing to generate positive financing cash flows. While management is optimistic about its ability to raise substantial funds to continue as a going concern for one year following the financial statement issuance date, there can be no assurance that any such measures will be successful. We currently do not generate substantial revenue from product sales. Accordingly, we expect to rely primarily on equity and/or debt financings to fund our continued operations. The Company’s ability to raise additional funds will depend, in part, on the success of our product development activities, and other events or conditions that may affect the share value or prospects, as well as factors related to financial, economic and market conditions, many of which are beyond our control. There can be no assurances that sufficient funds will be available to us when required or on acceptable terms, if at all. Accordingly, management has concluded that these plans do not alleviate substantial doubt about the Company’s ability to continue as a going concern.

2. Summary of Significant Accounting Policies

Basis of Presentation

The accompanying condensed consolidated financial statements as of and for the three months ended March 31, 2024 and 2023 have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) and pursuant to applicable rules and regulations of the Securities and Exchange Commission (“SEC”). These financial statements should be read in conjunction with the audited consolidated financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2023, which was filed with the SEC on March 7, 2024.

The accompanying unaudited condensed consolidated financial statements have been prepared on a consistent basis with the audited consolidated financial statements for the fiscal years ended December 31, 2023, and 2022, and include all adjustments, consisting of only normal recurring adjustments, necessary to fairly state the information set forth herein. There have been no changes to the Company’s significant accounting policies described in its Annual Report on Form 10-K for the fiscal year ended December 31, 2023 that have had a material impact on the consolidated financial statements and the related notes.

The results reported for the interim period presented are not necessarily indicative of results that may be expected for any subsequent quarter or for the full year ending December 31, 2024. These unaudited condensed consolidated financial statements include all adjustments and accruals that are necessary for a fair statement of all interim periods reported herein.

Principles of Consolidation

The condensed consolidated financial statements include the accounts of Cyngn Inc. and its wholly owned subsidiaries, including the dissolved subsidiary Cyngn Philippines, Inc. The Company investigated economic viability in the Philippines and determined it cost more to operate the subsidiary than any profit it could generate. Consequently, the subsidiary was shut-down, which had minimal impact on our condensed consolidated financial statements. Intercompany accounts and transactions have been eliminated upon consolidation.

Foreign Currency Translation

The functional and reporting currency for Cyngn is the U.S. dollar. Monetary assets and liabilities denominated in currencies other than U.S. dollar are translated into the U.S. dollar at period end rates, income and expenses are translated at the weighted average exchange rates for the period and equity is translated at the historical exchange rates. Foreign currency translation adjustments and transactional gains and losses are immaterial to the condensed consolidated financial statements.

Use of Estimates

The preparation of condensed consolidated financial statements in conformity with GAAP requires management to make certain estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the balance sheet date, as well as reported amounts of revenue and expenses during the reporting period. The Company’s significant estimates and judgments include but are not limited to internal-use software and developed software to be sold, leased or marketed, warrants and share-based compensation. Management bases its estimates on historical experience and on various other assumptions believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results could differ from those estimates.

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash, which is placed with high-credit-quality financial institutions and at times exceeds federally insured limits.

Cash maintained with domestic financial institutions generally exceed the Federal Deposit Insurance Corporation insurable limit. To date, the Company has not experienced any losses on its deposits of cash. Cyngn invests in U.S. Treasury securities and carries these at amortized cost and recognizes gains and losses when realized.

Concentration of Supplier Risk

The Company generally utilizes suppliers for outside development and engineering support. The Company does not believe that there is any significant supplier concentration risk as of March 31, 2024 and December 31, 2023.

Cash and Short-term Investments

The Company considers its bank accounts and all highly liquid investments that are both readily convertible to cash with minimal risk of changes in value due to changes in interest rates, to be cash. As of March 31, 2024 and December 31, 2023, the Company had $2.2 million and $3.6 million of cash, respectively.

The Company considers short-term investments to include marketable U.S. government securities that it intends to hold until maturity and redeem within one year. The Company treated its U.S. government treasury bill placements as held-to-maturity securities in accordance with the Financial Accounting Standards Board’s (“FASB”) Accounting Standards Codification Topic (“ASC”) 320, “Investments – Debt and Equity Securities”, and recorded these securities at amortized cost on the accompanying consolidated balance sheet as of March 31, 2024 and December 31, 2023.

Accounts Receivable

Accounts receivables are recorded at the invoiced amount and do not bear interest. The Company provides for probable uncollectible amounts based upon its assessment of the current status of the individual receivables and after using reasonable collection efforts. The allowance for doubtful accounts was zero as of March 31, 2024 and December 31, 2023. In addition, the Company utilizes current and historical collection data as well as assesses current economic conditions in order to determine expected trade credit losses on a prospective basis. No credit losses were recorded as of March 31, 2024 and December 31, 2023.

Fair Value Measurements

The accounting guidance under ASC Topic 820, “Fair Value Measurement”, defines fair value, establishes a consistent framework for measuring fair value, and expands disclosure for each major asset and liability category measured at fair value on either a recurring or nonrecurring basis. Fair value is defined as an exit price representing the amount that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants. As such, fair value is considered a market-based measurement that should be determined based on assumptions that market participants would use in pricing an asset or liability.

The Company uses the following fair value hierarchy prescribed by U.S. GAAP, which prioritizes the inputs used to measure fair value as follows:

Level 1—Unadjusted quoted prices in active markets for identical assets or liabilities.

Level 2—Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

Assets and liabilities are considered to be fair valued on a recurring basis if fair value is measured regularly. However, if the fair value measurement of an instrument does not necessarily result in a change in the amount recorded on the condensed consolidated balance sheets, assets and liabilities are considered to be fair valued on a nonrecurring basis. This typically occurs when accounting guidance requires assets and liabilities to be recorded at the lower of cost or fair value, or on certain nonfinancial assets and liabilities. Nonfinancial assets and liabilities that are measured at fair value on a nonrecurring basis include certain long-lived assets, intangible assets, and share-based compensation measured at fair value upon initial recognition.

The carrying amounts of the Company’s cash and accounts payable are reasonable estimates of their fair values due to their short-term nature. The fair values of the Company’s share-based compensation and underwriter warrants were based on observable inputs and assumptions used in Black-Scholes valuation models derived from independent external valuations.

Property and Equipment

Property and equipment is stated at cost less accumulated depreciation. Construction work in progress includes production costs and costs of materials used in the development of the Company’s autonomous driving software. Assets are held as construction work in progress until placed into service, at which date depreciation commences over the estimated useful lives of the respective assets. Depreciation is recorded on a straight-line basis over each asset’s estimated useful life. Repair and maintenance costs are expensed as incurred.

Property and Equipment		Useful life
Internal-use software		3 to 5 years
Computer and equipment		5 years
Furniture and fixtures		7 years
Leasehold improvements		Shorter of 3 years or lease term
Vehicles		5 years

Leases

The Company accounts for leases in accordance with ASC Topic 842 (“ASC 842”), “Leases”. All contracts are evaluated to determine whether or not they represent a lease. A lease conveys the right to control the use of an identified asset for a period of time in exchange for consideration. Leases are classified as finance or operating in accordance with the guidance in ASC 842. The Company does not hold any finance leases. The Company recognized a right-of-use asset and lease liability in the condensed consolidated balance sheets under ASC 842 on the office space lease that was amended and renewed until May 2025. Lease expense will be recognized on a straight-line basis over the remaining term of the lease. Operating leases are recognized on the balance sheet as right-of-use assets, and operating lease liabilities.

Costs to Develop Software

The Company incurs costs related to internally developed software. Based on the nature of the software, the Company capitalizes software costs under the following guidance.

Internal-Use Software costs

The Company determined when to capitalize its internal-use software after planning and design efforts are successfully completed. Management has implicitly authorized funding and the software is expected to be completed and used as intended. The Company determines the amount of internal software costs to be capitalized based on the amount of time spent by the developers on projects in the application stage of development. There is judgment involved in estimating time allocated to a particular project in the application stage. Costs associated with building or significantly enhancing the internally built software platform for internal use are capitalized, while costs associated with planning new developments and maintaining the internally built software platforms are expensed as incurred. Capitalized costs include certain payroll and stock compensation costs, as well as subscription server and consulting costs.

Internal-use software is classified as property and equipment and is amortized on a straight-line basis over their estimated useful life of three to five years. There is judgment involved in the determination of the useful life. Amortization of the software asset will begin when the software is substantially complete and ready for its intended use. No amortization has begun for the internal use software, as the projects are still in the application development phase. Management evaluates the useful lives of these assets on a quarterly basis and tests for impairment whenever events or changes in circumstances occur that could impact the recoverability of these assets. No impairment charges were associated with the Company’s internal-use software for the three months ended March 31, 2024 and 2023.

Costs to Develop Software to be Sold, Leased or Otherwise Marketed

The Company accounts for research costs of computer software to be sold, leased or otherwise marketed as expense until technological feasibility has been established for the product. Once technological feasibility is established, certain payroll and stock compensation, occupancy, and professional service costs that are incurred to develop functionality for the Company’s software and internally built software platforms, as well as certain upgrades and enhancements that are expected to result in enhanced functionality are capitalized. Judgment is required in determining when technological feasibility of a product is established. Management has determined that technological feasibility is established when a working model is complete.

Computer software to be sold, leased or otherwise marketed is classified as an intangible asset. Capitalized software development costs are amortized using the greater of (a) the amount computed using the ratio that current gross revenue for a product bear to the total of current and anticipated future gross revenue for that product or (b) the straight-line method, beginning upon commercial release of the product, and continuing over the remaining estimated economic life of the product, not to exceed three years to five years and recorded as cost of revenue. Amortization will begin when the product or enhancement is available for general release to customers. No amortization has begun for externally sold software, as the software enhancement is still in development. Management evaluates the useful lives of these assets on a quarterly basis and tests for impairment whenever events or changes in circumstances occur that could impact the recoverability of these assets. No impairment charges were associated with the Company’s sold, leased or otherwise marketed software for the three months ended March 31, 2024 and 2023.

Long-Lived Assets and Finite Lived Intangibles

The Company has finite-lived intangible assets consisting of patents and trademarks. These assets are amortized on a straight-line basis over their estimated remaining economic lives. The patents and trademarks are amortized over 15 years.

On April 1, 2022, the Company entered into an agreement for exclusive rights to certain hardware and software products and the rights to subsequently sell the software products and accompanying services. The Company paid a purchase price of $100,000 for these rights. The Company evaluated if substantially all of the assets acquired are concentrated in a single identifiable asset or group of similar identifiable assets to determine if the transaction should be accounted for as an asset acquisition. Since the only substantive assets acquired pertained to rights to intellectual property, the entire purchase price was allocated to intellectual property and accounted for as intangible assets with a useful life of 15 years. In accordance with ASC 805-50, “Business Combination”, the agreement was treated as an asset acquisition rather than a business combination. For the year ended December 31, 2023 the Company determined the existence of an impairment associated with the Company’s intangible asset “Rights to intellectual property” and accordingly recorded an impairment charge of $30,000. As of March 31, 2024, right to intellectual property is zero.

The Company reviews its long-lived assets and finite-lived intangibles for impairment whenever events or changes in circumstances indicate that the carrying value may not be recoverable. The events and circumstances the Company monitors and considers include significant decreases in the market price of similar assets, significant adverse changes to the extent and manner in which the asset is used, an adverse change in legal factors or business climate, an accumulation of costs that exceed the estimated cost to acquire or develop a similar asset, and continuing losses that exceed forecasted costs. The Company assesses the recoverability of these assets by comparing the carrying amount of such assets or asset group to the future undiscounted cash flow it expects the assets or asset group to generate. The Company recognizes an impairment loss if the sum of the expected long-term undiscounted cash flows that the long-lived asset is expected to generate is less than the carrying amount of the long-lived asset being evaluated. An impairment charge would then be recognized equal to the amount by which the carrying amount exceeds the fair value of the asset. For the period ended March 31, 2023, there were no impairment charges. For the three months ended March 31, 2024, the Company determined the existence of an impairment associated with the Company’s intangible asset “Patents” and accordingly recorded an impairment charge of $52,713. (See Note 6. Intangible Assets).

Income Taxes

The Company accounts for income taxes using the asset and liability method, under which deferred tax assets and liabilities are recognized for the expected future tax consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax basis.

A valuation allowance is provided when it is more likely than not that some portion or all of a deferred tax asset will not be realized. Due to the Company’s lack of earnings history, the net deferred tax assets have been fully offset by a valuation allowance as of March 31, 2024 and December 31, 2023 (see Note 11. Income Taxes).

There are no uncertain tax positions that would require recognition in the condensed consolidated financial statements. If the Company were to incur an income tax liability in the future, interest on any income tax liability would be reported as interest expense and penalties on any income tax would be reported as income taxes. Management’s conclusions regarding uncertain tax positions may be subject to review and adjustment at a later date based upon ongoing analysis of or changes in tax laws, regulations and interpretations thereof as well as other factors.

Common Stock Warrants

The Company issued to its lead underwriter in the Company’s IPO warrants to purchase up to 140,000 shares of the Company’s common stock. In addition, the Company issued 7,096,776 common stock warrants as a part of the private placement offering in April 2022. The Company accounts for warrants in accordance with ASC 480, “Distinguishing Liabilities from Equity”. The Company determined the fair value of the warrants using the Black-Scholes pricing model and treated the warrants as equity instruments in consideration of the cashless settlement provisions in the warrant agreements.

The Company also applied the guidance in ASC 340-10-S99-1, “Other Assets and Deferred Costs”, that states specific incremental costs directly attributable to a proposed or actual offering of equity securities may properly be deferred and charged against the gross proceeds of the offering. The Company treated the valuation of the warrants as directly attributable to the issuance of an equity contract and, accordingly, classified the warrants as additional paid-in capital.

Stock-based Compensation

The Company recognizes the cost of share-based awards granted to employees and directors based on the estimated grant-date fair value of the awards. Cost is recognized on a straight-line basis over the service period, which is generally the vesting period of the award. The Company recognizes stock-based compensation cost and reverses previously recognized costs for unvested awards in the period forfeitures occur, if any. The Company determines the fair value of stock options using the Black-Scholes option pricing model, which is impacted by the fair value of common stock, expected price volatility of common stock, expected term, risk-free interest rates, and expected dividend yield (see Note 9. Stock-based Compensation Expense).

Net Loss Per Share Attributable to Common Stockholders

The Company computes loss per share attributable to common shareholders by dividing net loss attributable to common shareholders by the weighted-average number of common shares outstanding. Diluted net loss per share reflects the potential dilution that could occur if securities or other contracts to issue shares were exercised into shares. In calculating diluted net loss per share, the numerator is adjusted for the change in the fair value of the shares (only if dilutive) and the denominator is increased to include the number of potentially dilutive common shares assumed to be outstanding (see Note 8. Net Loss per Share Attributable to Common Stockholders).

Research and Development Expense

Research and development expense consists primarily of outsourced engineering services, internal engineering and development expenses, materials, labor and stock-based compensation of Company personnel involved in the development of the Company’s products and services, and allocated lease costs based on the approximate square footage area used in research and development activities. Research and development costs are expensed as incurred.

Selling, General, and Administrative Expense

Selling, general, and administrative expense consist primarily of personnel costs, facilities expenses, depreciation and amortization, travel, and advertising costs. Advertising costs are expensed as incurred in accordance with ASC 720-35, “Other Expense – Advertising Costs”, other than trade show expenses which are deferred until occurrence of the future event. Advertising costs for the three months ended March 31, 2024 and 2023 were $91,099 and $23,814, respectively.

Commitments

The Company recognizes a liability with regard to loss contingencies when it believes it is probable a liability has occurred and the amount can be reasonably estimated. If some amount within a range of loss appears at the time to be a better estimate than any other amount within the range, the Company accrues that amount. When no amount within the range is a better estimate than any other amount the Company accrues the minimum amount in the range. There have been no such liabilities recorded by the Company as of March 31, 2024 and December 31, 2023.

Segment Reporting

The Company’s chief operating decision maker, its Chief Executive Officer, manages operations and business as one operating segment for the purposes of allocating resources, makes operating decisions and evaluates financial performance.

Revenue Recognition

Under ASC 606, “Revenue from Contracts with Customers”, the Company determines revenue recognition through the following steps:

●

Identifying the contract, or contracts, with the customer;

●

Identifying the performance obligations in the contract;

●

Determining the transaction price;

●

Allocating the transaction price to performance obligations in the contract; and

●

Recognizing revenue when, or as, the Company satisfies performance obligations by transferring the promised goods or services.

Nature of Products and Services and Revenue Recognition from (a) subscription of our Enterprise Autonomy Service (“EAS”), (b) nonrecurring engineering services under fixed fee arrangements (“NRE services”), and (c) product sales of hardware to customers and distributors, are recognized as follows:

Subscription

Subscription revenue primarily consists of the sale of SaaS offerings. Through the SaaS offerings and related support services, customers are granted access to a hosted software application over the contract period, generally ranging from one year to five years, without a contractual right to possession of the software.

SaaS and related support services: Revenues from the sale of hosted software applications and related support services are generally recognized ratably over the contractual period that the services are delivered, beginning on the date the service is made available to customers. Revenue is recognized ratably because the customer simultaneously receives and consumes the benefits of the services throughout the contract period. Contracts are generally fixed price the Company’s standard payment terms vary by customer and the products or services offered.

Revenue is measured based on considerations specified in a contract with a customer. Customer contracts for software subscriptions are generally represented by a sales contract or purchase order with contract durations typically ranging from three to five years.

For the three months ended March 31, 2024 and 2023, subscription revenue was $2,727 and $1,537, respectively.

Non-Recurring Engineering (“NRE”)

The Company enters into Non-Recurring Engineering (“NRE”) contracts that are principally comprised of engineering services related to customer-specific configuration of the DriveMod. Generally, with respect to these NRE contracts, i) the determination of the contract price is based on labor and hardware costs estimated to achieve the required milestones specified in the contract; ii) payment under these arrangements are comprised of upfront payments due upon execution of the agreements as well as payments due upon the achievement of milestones specified in each arrangement; and iii) contain mutual termination clauses without penalty. The Company recognizes revenue from NRE contracts that are fully funded by customers and the sale of its products when promised goods or engineering services are transferred to customers. Each of the Company’s NRE arrangements are comprised of multi-phase deliverables recognized at a point in time upon completion and acceptance from the customer of each phase of the arrangement. The Company recognizes revenue in an amount that reflects the consideration to which the Company expects to be entitled in exchange for those goods or services.

For the three months ended March 31, 2024 and 2023, NRE revenue was $0 and $870,000, respectively.

Hardware

Hardware Revenue generally consists of sale or lease of industrial vehicles modified with a proprietary autonomous kit, known as a DriveMod Kit. Revenue is recognized at a point in time when title and risks and rewards of ownership have transferred to the customer. Customer contracts for product sales of hardware are generally represented by a sales contract or purchase order.

For the three months ended March 31, 2024 and 2023, hardware revenue was $2,786 and $963, respectively.

Other:

Other revenues generally consist of fees associated with the sale of distinct professional services, either in support of deploying hardware and subscription support. Professional service offerings are typically sold as part of an arrangement for products or services included within subscription revenue. Professional services associated with subscription revenue generally relate to standard implementation, configuration, installation or training services applied to SaaS deployment models. Professional service revenue is recognized over time as the services are performed, as the customer simultaneously receives and consumes the benefit of these services. Professional service contracts are offered at either a fixed or a variable price and may be invoiced in advance or arrears of the services being provided.

The Company’s standard payment terms vary by customer and the products or services offered. Contract terms for other revenue arrangements are generally short-term, with stated contract terms that are less than one year.

The Company collects and remits taxes assessed by different governmental authorities that are both imposed on and concurrent with a revenue-producing transaction between the Company and the Company’s customers. These taxes may include, but are not limited to, sales, use, value-added, and some excise taxes. The Company reports the collection of these taxes on a net basis (excluded from revenues). Shipping and handling fees billed to customers are included in net sales, while costs of shipping and handling are included in cost of revenue.

For the three months ended March 31, 2024 and 2023, other revenue was $0 and $300, respectively.

Arrangements with Multiple Performance Obligations

When a contract involves multiple performance obligations, the Company accounts for individual products and services separately if the customer can benefit from the product or service on its own or with other resources that are readily available to the customer and the product or service is separately identifiable from other promises in the arrangement. The consideration is allocated between separate performance obligations in proportion to their estimated stand-alone selling price. The transactions to which the Company had to estimate stand-alone selling prices and allocate the arrangement consideration to multiple performance obligations were immaterial.

The Company’s contracts may include standard warranty or service level provisions that state promised goods and services will perform and operate in all material respects as defined in the respective agreements. The Company has determined that these represent assurance-type warranties, and the Company has not incurred any material costs as a result of such commitments.

Cost to Obtain and Fulfill a Contract. The Company incurs certain costs to obtain contracts, principally third-party fulfillment fees, which the Company capitalizes when the liability has been incurred if they are (i) incremental costs of obtaining a contract, (ii) expected to be recovered and (iii) have an expected amortization period that is greater than one year (as the Company has elected the practical expedient to expense any costs to obtain a contract when the liability is incurred if the amortization period of such costs would be one year or less).

Material Rights:

The Company’s contracts with customers may include renewal or other options at stated prices. Determining whether these options provide the customer with a material right and therefore need to be accounted for as separate performance obligations requires judgment. The price of each option must be assessed to determine whether it is reflective of the stand-alone selling price or is reflective of a discount that the customer only received as a result of its prior purchase (a material right).

Other Policies, Judgments and Practical Expedients

Contract balances. Contract assets and liabilities represent the differences in the timing of revenue recognition from the receipt of cash from the Company’s customers and billings. Contract assets reflect revenue recognized and performance obligations satisfied in advance of customer billing. Contract liabilities relate to payments received in advance of the satisfaction of performance under the contract. Receivable represents right to consideration that is unconditional. Such rights are considered unconditional if only the passage of time is required before payment of that consideration is due.

Remaining performance obligations. Revenue allocated to remaining performance obligations represents the transaction price allocated to the performance obligations that are unsatisfied, or partially unsatisfied. It includes unearned revenue and amounts that will be invoiced and recognized as revenue in future periods and does not include contracts where the customer is not committed. The customer is not considered committed where they are able to terminate for convenience without payment of a substantive penalty under the contract. The Company has

elected the optional exemption, which allows for the exclusion of the amounts for remaining performance obligations that are part of contracts with an original expected duration of one year or less.

Significant financing component. In certain arrangements, the Company receives payment from a customer either before or after the performance obligation has been satisfied. The Company’s contracts with customer prepayment terms do not include a significant financing component because the primary purpose is not to receive or provide financing from or to the customers.

Contract modifications. The Company may modify contracts to offer customers additional products or services. Each of the additional products and services are generally considered distinct from those products or services transferred to the customer before the modification. The Company evaluates whether the contract price for the additional products and services reflects the stand-alone selling price as adjusted for facts and circumstances applicable to that contract. In these cases, the Company accounts for the additional products or services as a separate contract. In other cases where the pricing in the modification does not reflect the stand-alone selling price as adjusted for facts and circumstances applicable to that contract, the Company accounts on a prospective basis where the remaining goods and services are distinct from the original items and on a cumulative catch-up basis when the remaining goods and services are not distinct from the original items.

Principal vs. Agent Considerations

Judgment is required in determining whether we are the principal or agent in transactions with dealers, OEMs and end-users. We evaluate the presentation of revenue on a gross or net basis based on whether we control the service provided to the end-user and are the principal (i.e., “gross”), or we arrange for other parties to provide the service to the end-user and are an agent (i.e., “net”). This determination also impacts the presentation of incentives provided to dealers and OEMs and discounts and promotions offered to end-users to the extent they are not customers.

In dealer transactions where our role is to provide the hardware to the dealer, we do not control and are not primarily responsible for the good or service provided by the dealer to end-users. In these transactions, hardware revenue is recorded on a net basis.

In dealer and OEM transactions where our role is to provide the software subscription to the end-user, we are primarily responsible for the services and present the respective subscription revenue on a gross basis. Payments to dealers in exchange for their services are recorded as cost of revenue.

Judgments and estimates. Accounting for contracts recognized over time involves the use of various techniques to estimate total contract revenue and costs. Due to uncertainties inherent in the estimation process, it is possible that estimates of costs to complete a performance obligation will be revised in the near term. The Company reviews and updates its contract-related estimates regularly, and records adjustments as needed. For those performance obligations for which revenue is recognized using a cost-to-cost input method and residual method, changes in total estimated costs, and related progress towards complete satisfaction of the performance obligation, are recognized on a cumulative catch-up basis in the period in which the revisions to the estimates are made.

Concentration of Credit Risk

The following table sets forth the percentages of total revenue for customers that represents 10% or more of the respective amounts for the three months ended March 31, 2024 and 2023, respectively.

	2024			2023
Customer A		*			76.8	%
Customer B		100	%		*

Below 10%

There were no accounts receivable from these customers at March 31, 2024 and December 31, 2023.

Cost of Revenue

Cost of revenue consists primarily of direct labor and related fringe benefits for internal engineering resources costs incurred for the completion of the contracts and hardware costs.

3. Revenue and Contracts with Customers

Contract Balances

Timing differences between revenue recognized, billings, and customer payments result in contract assets and liabilities. Contract assets represent revenue recognized in excess of customer billings. Contract liabilities represent payments received from customers in advance of satisfying performance obligations. The Company’s contract assets or liabilities as of March 31, 2024 and December 31, 2023 are not material.

Deferred Contract Costs

The Company defers costs associated with fulfilling its contracts if those costs meet all of the following criteria: (i) the costs relate directly to a contract, (ii) the costs generate or enhance resources of the Company that will be used in satisfying performance obligations in the future, and (iii) the costs are expected to be recovered. Deferred contract costs are included in prepaid and other current assets in the condensed consolidated balance sheets. The Company had no deferred contract costs as of March 31, 2024 and December 31, 2023, respectively.

4. Balance Sheet Components

Financial Instruments

The Company’s short-term investments consisted of U.S. government treasury bills, which are accounted for as held-to-maturity (“HTM”) securities. HTM securities are carried at amortized cost and, as a result, are not remeasured to fair value on a recurring basis. As of March 31, 2024 and December 31, 2023, the amortized cost of the Company’s U.S. government treasury bills totaled $2.6 million and $4.6 million, respectively, which approximated its fair value based on Level 1 inputs. All of the Company’s short-term investments will mature within one year of March 31, 2024. The Company does not expect a credit loss for its short-term investments.

Prepaid expenses and other current assets

Prepaid expenses and other current assets are comprised of the following:

	March 31, 2024		December 31, 2023
Inventory, net	$	70,280	$	-
Prepaid expenses		437,906		385,474
Security deposits		175,191		155,729
Tax receivables		763,624		765,697
Receivables and current assets		55,114		9,526
Total prepaid and expenses and other current assets	$	1,502,115	$	1,316,426

Property and Equipment, Net

Property and equipment is comprised of the following:

	March 31,			December 31,
	2024			2023
Automobiles	$	656,997		$	616,947
Furniture and fixtures		178,491			178,491
Computer and equipment		529,541			517,181
Capitalized software		444,115			342,136
Leasehold improvements		208,848			458,406
Construction work in progress		518,255			208,848
Property and equipment, gross		2,536,247			2,322,009
Less: accumulated depreciation		(883,865	)		(835,337	)
Total property and equipment, net	$	1,652,382		$	1,486,672

Depreciation expense for the three months ended March 31, 2024 and 2023 was $48,528 and $81,464, respectively.

Accounts Payable

Accounts payable includes independent director fees payable of $42,500 and $41,250 as of March 31, 2024 and December 31, 2023, respectively.

Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities are comprised of the following:

	March 31, 2024		December 31, 2023
Credit card payable	$	4,699	$	1,103
Accrued expenses		355,910		214,286
Accrued payroll		359,630		985,753
Total accrued expenses and other current liabilities	$	720,239	$	1,201,142

5. Operating Leases

The Company leases its office space in Menlo Park, California, under an operating lease agreement dated August 18, 2017, that was originally signed for a term of five years. The lease has been amended and extended several times since the original signing and currently expires in May 2025. Monthly payments are approximately $60,000. The lease includes common area maintenance costs that are paid separately from rent based on actual costs incurred.

The Company’s future lease payments under the non-cancellable lease as of March 31, 2024, which are presented as lease liabilities on the Company’s condensed consolidated balance sheet, are as follows:

Period	Operating Lease
Remainder of 2024	$	553,636
2025		320,526
Total lease payments		874,162
Less: imputed interest		(21,936	)
Present value of lease liability	$	852,226

	March 31,			December 31,
	2024			2023
Weighted-average remaining lease term (in years)		1.17			1.42
Weighted -average discount rate		3.60	%		3.05	%

Lease expense under the Company’s operating lease was $180,660 and $142,586 for the three months ended March 31, 2024 and 2023, respectively. The amortization of the operating lease right-of-use assets totaled $171,148 and $138,020 for the three months ended March 31, 2024 and 2023, respectively. The weighted-average discount rate is based on the implicit interest rate of the present value of the remaining lease payments and the remaining lease term.

6. Intangible Assets, Net

The gross carrying amount and accumulated amortization of separately identifiable intangible assets are as follows:

	As of March 31, 2024
	Gross Carrying Amount		Accumulated Amortization			Impairment			Net Carrying Amount
Developed software	$	542,692	$	-		$	-		$	542,692
Patents		559,474		(25,281	)		(52,723	)		481,470
Trademark		45,000		(23,750	)		-			21,250
Total intangible assets	$	1,147,166	$	(49,031	)	$	(52,723	)	$	1,045,412

	As of December 31, 2023
	Gross Carrying Amount		Accumulated Amortization			Fair Market Value Adjustment			Impairment			Net Carrying Amount
Developed software	$	542,692	$	-		$	-		$	-		$	542,692
Patents		539,840		(20,117	)		-			-			519,723
Trademark		45,000		(23,000	)		-			-			22,000
Rights to intellectual property		100,000		(20,000	)		(50,000	)		(30,000	)		-
Total intangible assets	$	1,227,532	$	(63,117	)	$	(50,000	)	$	(30,000	)	$	1,084,415

Amortization expense for each of the three months ended March 31, 2024 and 2023 was $5,914 and $8,547, respectively.

ASC 360, “Property, Plant, and Equipment”, defines a multi-step process to test long-lived assets, including intangible assets, for recoverability that if failed would indicate impairment. First, the Company must consider whether indicators of impairment of long-lived assets are present. The Company determined the Triggering Events in conjunction with preparation of its financial statements for the year ended December 31, 2023 provided such indication.

Next, the Company must review the long-lived assets to define asset group(s) that would reflect the lowest level of assets to which discrete cash flows are identifiable, and test these asset groups for impairment.

In performing this review, the Company identified that the long-lived asset “Patents”, which have international and U.S. based patents, as the asset group. The Company evaluated its patents and identified expired international patent applications (“expired assets”) for the three months ended March 31, 2024. The Company determined there were no further plans to put resources toward these international patent applications. The group of expired patents carrying value was set to its salvage value which is zero given no future cash flows.

For the three months ended March 31, 2024, the Company recorded a $52,723 impairment charge under gain (loss) on disposal assets, which is included in other income (expense) on its condensed consolidated statement of operations, to adjust the expiring assets salvage value of zero.

The Company identified that the long-lived asset “Rights to intellectual property”, all of which relate to the Infinitracker, should be classified as abandoned (the “Abandoned Asset”) with the Company determining that it no longer has plans to provide support and sale of the product. The Abandoned Asset’s carrying value was set to its salvage value which is zero given no future cash flows. In addition, the Company abandoned the use of the associated inventory and recorded a loss of $66,690 to impair the inventory to $0 as of December 31, 2023.

The impairment charges as of December 31, 2023, the Company recorded a fair market value adjustment of $50,000 and a $30,000 impairment charge under amortization expense on its condensed consolidated statement of operations to adjust the Abandoned Asset to its salvage value of zero.

It was determined for all remaining long-lived assets (excluding the Abandoned Asset) that there were no triggering events, and therefore, no further impairment charges to long-lived assets were necessary as of March 31, 2024 and December 31, 2023.

Estimated amortization expense for all intangible assets subject to amortization in future years is expected to be:

	Amortization
Remainder 2024	$	17,740
2025		23,654
2026		23,654
2027		23,654
2028		23,654
Thereafter		933,056
Total	$	1,045,412

7. Capital Structure

Common Stock

As of March 31, 2024 and December 31, 2023, the Company is authorized to issue 200,000,000 shares of common stock with a par value of $0.00001 per share. As of March 31, 2024 and December 31, 2023, the Company had 88,454,654 and 64,773,756 shares of common stock issued and outstanding, respectively. Holders of common stock have no pre-emptive, conversion or subscription rights and there is no redemption or sinking fund provisions applicable to the common stock. The rights, preferences and privileges of the holders of common stock are subject to, and may be adversely affected by, the rights of the holders of shares of any series of preferred stock that the Company may designate in the future.

Preferred Stock

In October 2021, the Company amended its Certificate of Incorporation and revised the number of preferred stock shares authorized for issuance to 10,000,000 shares at a par value of $0.00001. As of March 31, 2024 and December 31, 2023, there were no shares of preferred stock issued and outstanding.

Common Stock Offering

On December 8, 2023, the Company entered into a Placement Agent Agreement with Aegis Capital Corp. (“Aegis”), pursuant to which Aegis acted as the Company’s placement agent, on a reasonable best efforts basis, in connection with the sale by the Company of an aggregate of 33,333,333 shares of common stock in a public offering, which included: (i) 11,466,733 shares of common stock, and (ii) pre-funded warrants to purchase 21,866,600 shares of common stock. The Pre-Funded Warrants had a nominal exercise price of $0.00001. Each share of common stock was sold at an offering price of $0.15, and each Pre-Funded Warrant was sold at an offering price of $0.14999.

The public offering closed on December 12, 2023. The Company received gross proceeds of approximately $5 million before deducting transaction related expenses payable by the Company. All commissions, qualified legal, accounting, registration and other direct costs of $0.5 million related to the public offering were offset against the gross proceeds. The Company is using the net proceeds to fund its cash needs.

At the Market Equity Financing

On May 31, 2023, the Company entered into an ATM Sales Agreement with Virtu Americas LLC (the “ATM Sales Agreement”), under which the Company may, from time to time, sell shares of the Company’s common stock at market prices by methods deemed to be an “at-the-market offering” as defined in Rule 415 promulgated under the Securities Act of 1933, as amended. The ATM Sales Agreement and related prospectus is limited to sales of up to an aggregate maximum $8.8 million of shares of the Company’s common stock. The Company pays Virtu Americas LLC up to 3.0% of the gross proceeds as a commission. For the three months ended as of March 31, 2024, a total of 17,034,205 shares of common stock were sold through Virtu Americas LLC under the ATM Sales Agreement for net proceeds of $4,460,639 after payment of commission fees of $91,033 and other related expenses of $60,465.

Private Placement Offering

On April 28, 2022, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with certain accredited and institutional investors for a private placement offering (“Private Placement”) of the Company’s common stock (the “Common Stock”) and pre-funded warrants (the “Pre-Funded Warrants”) and warrants exercisable for Common Stock (the “Common Stock Warrants”). Pursuant to the Purchase Agreement, the Company sold (i) 3,790,322 shares of its Common Stock together with Common Stock Warrants to purchase up to 3,790,322 shares of Common Stock, and (ii) 2,661,291 Pre-Funded Warrants with each Pre-Funded Warrant exercisable for one share of Common Stock, together with Common Stock Warrants to purchase up to 2,661,291 shares of Common Stock. The Common Stock Warrants totaled 6,451,613. As a result of the stock dividend in October 2023, the total warrants outstanding was adjusted to 7,096,776. The Company allocated the proceeds between the Common Stock, Pre-Funded Warrants, and Common Stock Warrants on a relative fair value basis and recorded the amount allocated to the Common Stock Warrants within additional paid-in capital on the accompanying consolidated balance sheet as the Common Stock Warrants met all the criteria for equity classification. As the Common Stock Warrants were equity classified, they do not require subsequent remeasurement after the issuance (see below).

The Pre-Funded Warrants were exercised in full in May 2022 at a nominal exercise price of $0.001. Each share of Common Stock and accompanying Common Stock Warrant were sold together at a combined offering price of $3.10, and each Pre-Funded Warrant and accompanying Common Stock Warrant were sold together at a combined offering price of $3.09.

The Common Stock Warrants have an exercise price of $2.98 per share (subject to adjustment as set forth in the warrant), are exercisable upon issuance and will expire five years from the date of issuance. The Common Stock Warrants contain standard adjustments to the exercise price including for stock splits, stock dividends, rights offerings and pro rata distributions. As a result of the stock dividend in October 2023, the exercise price was adjusted to $2.71. There were no Common Stock Warrants exercised as of March 31, 2024 and December 31, 2023 (see below).

The Private Placement closed on April 29, 2022. The Company received gross proceeds of approximately $20 million before deducting transaction related expenses payable by the Company. All qualified legal, accounting, registration and other direct costs related to the Private Placement were offset against the gross proceeds. The Company is using the net proceeds to fund its cash needs.

Common Stock Warrants

The following warrants were outstanding as of March 31, 2024 and December 31, 2023, all of which contain standard anti-dilution protections in the event of subsequent rights offerings, stock splits, stock dividends or other extraordinary dividends, or other similar changes in the Company’s common stock or capital structure, and none of which have any participating rights for any losses:

Securities into which warrants are convertible	Warrants outstanding		Exercise Price		Expiration Date	Fair value
Common stock (Initial Public Offering)		140,000	$	9.375	October 2026	$	170,397
Common stock (Private Placement)		7,096,776	$	2.71	April 2027		6,745,681
Total		7,236,776				$	6,916,078

The Company accounts for warrants in accordance with ASC 480, “Distinguishing Liabilities from Equity”, depending on the specific terms of the warrant agreement. The Company determined the fair value of the warrants using the Black-Scholes pricing model and treated the valuation as equity instruments in consideration of the cashless settlement provisions in the warrant agreements. The warrants are not marked-to-market each reporting period, and thus there is no impact to earnings. Any future exercises of the warrants will be recorded as cash received and recorded in cash, with a corresponding increase to common stock and additional paid-in capital in stockholders’ equity.

The Company used the following assumptions:

	Initial Public Offering Warrants			Private Placement Warrants
Fair value of underlying securities	$	2.88		$	1.37
Expected volatility		51.0	%		45.0	%
Expected term (in years)		5.0			5.0
Risk-free interest rate		1.13	%		2.92	%

8. Net Loss Per Share Attributable to Common Stockholders

The Company declared a 10% stock dividend that was distributed on October 30, 2023 to shareholders of record on October 23, 2023. In accordance with ASC 260, “Earnings Per Share”, basic and diluted earnings per shares amounts, and weighted-average shares outstanding have been restated for all periods presented to reflect the effect of these stock dividends. The following table summarizes the computation of basic and diluted loss per share:

The following table summarizes the computation of basic and diluted loss per share:

	Three months Ended March 31,
	2024			2023
Net loss attributable to common stockholders	$	(5,970,079	)	$	(5,628,758	)

Basic and diluted weighted average common shares outstanding		77,081,105			37,685,413

Loss per share:
Basic and diluted	$	(0.08	)	$	(0.15	)

Basic loss per share is based upon the weighted average number of shares of common stock outstanding during the period. Diluted loss per share would include the effect of unvested restricted stock awards and the convertible preferred stock; however, such items were not considered in the calculation of the diluted weighted average common shares outstanding since they would be anti-dilutive.

9. Stock-based Compensation Expense

Stock-Based Compensation

The Company uses stock-based compensation, including restricted stock units, to provide long-term performance incentives for its employees and board directors. The Company measures employee and director stock-based compensation awards based on the award’s estimated fair value on the date of grant. Forfeitures are recognized as they occur. Expense associated with these awards is recognized using the straight-line attribution method over the requisite service period for stock options, restricted stock units (“RSUs”) and restricted stock and is reported in our condensed consolidated statements of stockholders’ equity.

The fair value of the Company’s stock options is estimated, using the Black-Scholes option-pricing model. The resulting fair value is recognized on a straight-line basis over the period during which an employee is required to provide service in exchange for the award. The Company has elected to recognize forfeitures as they occur. Stock options generally vest over four years and have a contractual term of ten years.

Determining the grant date fair value of options requires management to make assumptions and judgments. These estimates involve inherent uncertainties and if different assumptions had been used, stock-based compensation expense could have been materially different from the amounts recorded.

The assumptions and estimates for valuing stock options are as follows:

●

Fair value per share of Company’s common stock. Because there was no public market for Cyngn’s common stock prior to the IPO, its Board of Directors, with the assistance of a third-party valuation specialist, determined the common stock fair value at the time of the grant of stock options by considering a number of objective and subjective factors, including its actual operating and financial performance, market conditions and performance of comparable publicly traded companies, developments and milestones in the Company, and the likelihood of achieving a liquidity event among other factors. Since the Company’s common stock began publicly trading on the Nasdaq, the value of its common stock underlying stock options or RSUs has been valued based on prevailing market prices.

●

Expected volatility. Because the Company’s common stock had no publicly traded history prior to the IPO, it estimated the expected volatility using a combination of its stock price volatility and the stock price volatility of peer companies, for a period equal to the expected term of the options.

●

Expected term. The expected term of employee stock options represents the weighted-average period that the stock options are expected to remain outstanding. The Company estimates the expected term of options granted based upon the “simplified method” provided under Staff Accounting Bulletin, Topic 14, or SAB Topic 14.

●

Risk-free interest rate. The risk-free interest rate is based on the U.S. Treasury yield curve in effect during the period the options were granted corresponding to the expected term of the awards.

●

Estimated dividend yield. The estimated dividend yield is zero, as the Company does not currently intend to declare dividends in the foreseeable future.

Equity Incentive Plans

In February 2013, the Company’s Board of Directors adopted the 2013 Equity Incentive Plan (“2013 Plan”). The 2013 Plan authorizes the award of stock options, stock appreciation rights, restricted stock awards, stock appreciation rights, RSUs, performance awards, and other stock or cash awards.

In October 2021, the Company’s Board of Directors adopted the Cyngn Inc. 2021 Equity Incentive Plan (the “2021 Plan”). The 2021 Plan replaces the 2013 Plan. However, awards outstanding under the 2013 Plan will continue to be governed by their existing terms.

In November 7, 2023, the shareholders of the Company approved an amendment to the Company’s 2021 Equity Incentive Plan to increase the number of shares authorized for issuance by 5,000,000 shares of common stock and to allow an annual increase to the 2021 Plan equal to the least of (i) 5% of the outstanding common stock on a fully diluted basis as of the end of the Company’s immediately preceding fiscal year, (ii) 2,500,000 shares, or (iii) a lesser amount as determined by the Board.

As of March 31, 2024 and December 31, 2023, approximately 8.6 million and approximately 0.7 million shares of common stock were reserved and available for issuance under the 2021 Plan, respectively.

Options issued under the Plans generally vest based on continuous service provided by the option holder over a four-year period. Compensation expense related to these options is recognized on a straight-line basis over the four-year period based upon the fair value at the grant date.

The following table summarizes information about the Company’s stock options outstanding as well as stock options vested and exercisable as of March 31, 2024, and activity during the three month period then ended:

	Shares			Weighted-average exercise price		Weighted-average remaining contractual term (years)		Aggregate intrinsic value
Outstanding as of December 31, 2023		17,503,253		$	1.04		7.37	$	42,527
Granted		245,500			0.20
Exercised		-			-				-
Cancelled/forfeited		(631,354	)	$	1.32
Outstanding as of March 31, 2024		17,117,399		$	1.02		7.11	$	104,727
Vested and expected to vest at March 31, 2024		17,117,399		$	1.02		7.11	$	104,727
Vested and exercisable at March 31, 2024		9,205,674		$	0.96		5.68	$	104,727

The following table summarizes information about the Company’s RSUs as of March 31, 2024, and activity during the three months then ended:

	Shares			Weighted- average grant date fair value
Unvested Shares at December 31, 2023		177,294		$	2.80
RSUs granted		-			-
RSUs vested		(12,228	)		5.52
RSUs forfeited		-			-
Unvested Shares at March 31, 2024		165,066		$	2.60

The fair value of a stock option is estimated using an option-pricing model that takes into account as of the grant date the exercise price and expected life of the option, the current price of the underlying stock and its expected volatility, expected dividends on the stock, and the risk-free interest rate for the expected term of the option. The Company has used the simplified method in calculating the expected term of all option grants based on the vesting period and contractual term. Compensation costs related to share-based payment transactions are recognized in the financial statements upon satisfaction of the requisite service or vesting requirements.

The weighted average per share grant-date fair value of options granted during the three months ended March 31, 2024 and 2023 was $0.11 and $0.57, respectively.

The following weighted average assumptions were used in estimating the grant date fair values for the three months ended March 31, 2024 and 2023:

	March 31,
	2024			2023
Fair value of common stock	$	0.20		$	1.06
Expected term (in years)		6.01			6.03
Risk-free rate		4.10	%		3.73	%
Expected volatility		53.06	%		52.50	%
Dividend yield		0	%		0	%

For the three months ended March 31, 2024 and 2023, the Company recorded stock-based compensation expense from stock options and RSUs of approximately $654,000 and $925,000, respectively.

As of March 31, 2024, total stock-based compensation cost related to outstanding unvested stock options that are expected to vest was $ 5.7 million. This unrecognized stock-based compensation cost is expected to be recognized over a weighted-average period of approximately 2.6 years. Income tax benefits recognized from stock-based compensation expense recognized for the year ended March 31, 2024 were immaterial due to cumulative losses and valuation allowances.

10. Retirement Savings Plan

Effective November 17, 2017, the Company established the Cyngn Inc. 401(k) Plan for the exclusive benefit of all eligible employees and their beneficiaries with the intention to provide a measure of retirement security for the future. This plan is subject to the provisions of the Employee Retirement Income Security Act of 1974 (ERISA) and qualifies under Section 401(k) of the Internal Revenue Code. Cyngn Inc. did not offer and has not provided a company match for its 401(k) Plan.

11. Income Taxes

For the three months ended March 31, 2024 and 2023, the Company recorded income tax expense of $0. The effective tax rate is 0% for the three months ended March 31, 2024 and 2023.

For financial reporting purposes, the Company’s effective tax rate used for the interim periods is based on the estimated full-year income tax rate. For the three months ended March 31, 2024, the Company’s effective tax rate differs from the statutory rate, primarily due to a valuation allowance recorded against the net deferred tax asset balance.

Currently, the Company is not under examination by any taxing authority.

12. Commitments and Contingencies

Legal Proceedings

The Company is subject to legal and regulatory actions that arise from time to time. The assessment as to whether a loss is probable or reasonably possible, and as to whether such loss or a range of such loss is estimable, often involves significant judgment about future events, and the outcome of litigation is inherently uncertain. There is no material pending or threatened litigation against the Company that remains outstanding as of March 31, 2024 and December 31, 2023.

Nasdaq Compliance

On August 24, 2023, the Company received a notification letter from The Nasdaq Stock Market advising that, for 30 consecutive business days preceding the notification letter, the Company did not meet the minimum $1.00 per share bid price requirement for continued inclusion on The Nasdaq Capital Market pursuant to Nasdaq Marketplace Listing Rule 5550(a)(2). To demonstrate compliance with this requirement, the closing bid price of the Company’s common stock needs to be at least $1.00 per share for a minimum of 10 consecutive business days before February 20, 2024. On February 21, 2024, Nasdaq granted the Company an additional 180-day extension to continue its listing on the Nasdaq Capital Market. The Company was given until August 19, 2024 to regain compliance with Nasdaq’s $1 minimum bid price per share requirement.

13. Risks and Uncertainties

The Company’s business operations, operating results, and financial condition are vulnerable to certain risks and uncertainties including:

●

Inflation and its related impact on costs and expenditures on domestic and foreign-sourced materials and services;

●

Rising interest rates and its impact on the equity markets, investment valuations, and interest rate-sensitive calculations such as discount rate assumptions used in cash flow projections and going-concern assessments;

●

Effects of the Russia-Ukraine and Israeli-Palestine conflicts such as possible cyberattacks and potential disruptions in the banking systems and capital markets and the supply chain; and

●

Other factors beyond its control such as natural disasters, terrorism, civil unrest, infectious diseases and pandemics including COVID-19 and its variants.

The Company is unable to predict and quantify at this time the extent of the related potential adverse effects but continuously monitors these risks and uncertainties on its future operations and financial performance.

14. Subsequent Events

ATM

As of May 8, 2024, the Company has sold 931,910 additional shares under the ATM Sales Agreement, for net proceeds of $141,320 after payment of commission and fees of $2,884.

Common Stock Offering

As of April 23, 2024, the Company entered into an underwritten Agreement with Aegis Capital Corp. (“Aegis”), pursuant to which Aegis acted as the Company’s underwriter on a firm commitment basis in connection with the sale by the Company of an aggregate of 50,000,000 shares of common stock in a public offering, which included: (i) 19,800,000 shares of common stock, and (ii) pre-funded warrants to purchase 30,200,000 shares of common stock. The Pre-Funded Warrants had a nominal exercise price of $0.00001. Each share of common stock was sold at an offering price of $0.10, and each Pre-Funded Warrant was sold at an offering price of $0.09999. The offering closed on April 25, 2024.

On May 3, the Company closed on the sale of an additional 2,040,000 shares of common stock, upon exercise by the underwriter of the over-allotment option.

The Company received gross proceeds of approximately $5.2 million before deducting transaction related expenses payable by the Company. All commissions, qualified legal, accounting, registration and other direct costs of $0.6 million related to the public offering were offset against the gross proceeds. The Company is using the net proceeds to fund its cash needs.

Israeli Entity

As of May 8, 2024, the Company is in the process of creating a wholly-owned entity in Israel for continued research and development efforts.

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

The objective of this Management’s Discussion and Analysis is to allow investors to view the Company from management’s perspective, considering items that would have a material impact on future operations. The following discussion and analysis of our financial condition and results of operations should be read in conjunction with our condensed consolidated financial statements and the accompanying notes thereto included elsewhere in this Quarterly Report on Form 10-Q and our Annual Report on Form 10-K for the fiscal year ended December 31, 2023 (the “Form 10-K”), which we filed with the U.S. Securities and Exchange Commission (“SEC”) on March 7, 2024. The information in this discussion contains forward-looking statements and information within the meaning of Section 27A of the Securities Act of 1933, as amended, or the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended, or the Exchange Act, which are subject to the “safe harbor” created by those sections. These forward-looking statements include, but are not limited to, statements concerning our strategy, future operations, future financial position, future revenues, projected costs, prospects and plans and objectives of management. The words “anticipates,” “believes,” “estimates,” “expects,” “intends,” “may,” “plans,” “projects,” “will,” “would” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. We may not actually achieve the plans, intentions, or expectations disclosed in our forward-looking statements and you should not place undue reliance on our forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements that we make. These forward-looking statements involve risks and uncertainties that could cause our actual results to differ materially from those in the forward-looking statements, including, without limitation, the risks set forth in our other filings with the SEC, including the Form 10-K. The forward-looking statements are applicable only as of the date on which they are made, and we do not assume any obligation to update any forward-looking statements.

Unless the context requires otherwise, references in this Quarterly Report on Form 10-Q to “we,” “us,” “our,” and Cyngn refer to Cyngn Inc. and its consolidated subsidiaries.

Overview

We are an autonomous vehicle (“AV”) technology company that is focused on addressing industrial uses for autonomous vehicles. We believe that technological innovation is needed to enable adoption of autonomous industrial vehicles that will address the substantial industry challenges that exist today. These challenges include labor shortages, lagging technological advancements from incumbent vehicle manufacturers, and high upfront investment commitment.

Industrial sites are typically rigid environments with consistent standards as opposed to city streets that have more variable environmental and situational conditions and diverse regulations. These differences in operational design domains will be major factors that make proliferation of industrial AVs in private settings achievable with less time and resources than AVs on public roadways. Namely, safety and infrastructure challenges are cited as roadblocks that have delayed AVs from operating on public roadways at scale. Our focus on industrial AVs simplifies these challenges because industrial facilities (especially those belonging to a single end customer that operates similarly at different sites) share much more in common than different cities do. Furthermore, our end customers own their infrastructure and can make changes more easily than governments can on public roadways.

With these challenges in mind, we have developed an Enterprise Autonomy Suite (“EAS”) that leverages advanced in-vehicle autonomous driving technology and incorporates leading supporting technologies like data analytics, asset tracking, fleet management, cloud, and connectivity. EAS provides a differentiated solution that we believe drives pervasive proliferation of industrial autonomy and creates value for customers at every stage of their journey towards full automation and the adoption of Industry 4.0.

EAS is a suite of technologies and tools that we divide into three complementary categories:

	1.	DriveMod, our modular industrial vehicle autonomous driving software;

	2.	Cyngn Insight, our customer-facing tool suite for monitoring and managing AV fleets (including remotely operated vehicles) and generating/aggregating/analyzing data (including the IoT gateway device); and

Cyngn Evolve, our internal tool suite and infrastructure that facilitates artificial intelligence (“AI”) and machine learning (“ML”) training to continuously enhance our algorithms and models and provides a simulation framework (both record/rerun and synthetic scenario creation) to ensure that data collected in the field can be applied to validating new releases.

Legacy automation providers manufacture specialized industrial vehicles with integrated robotics software for rigidly defined tasks, limiting automation to narrow uses. Unlike these specialized vehicles, EAS can be compatible with the existing vehicle assets in addition to new vehicles that have been purposely built for autonomy by vehicle manufacturers. EAS is operationally expansive, vehicle agnostic, and compatible with indoor and outdoor environments. By offering flexible autonomous services, we aim to remove barriers to industry adoption.

We understand that scaling of autonomy solutions will require an ecosystem made up of different technologies and services that are enablers for AVs. Our approach is to forge strategic collaborations with complementary technology providers that accelerate AV development and deployment, provide access to new markets, and create new capabilities. Our focus on designing DriveMod to be modular will combine with our experience deploying AV technology on diverse industrial vehicle form factors, which will be difficult for competitors to replicate.

We expect our technology to generate revenue through two main methods: deployment and EAS subscriptions. Deploying our EAS requires us and our integration partners to work with a new client to map the job site, gather data, and install our AV technology within their fleet and site. We anticipate that new deployments will yield project-based revenues based on the scope of the deployment. After deployment, we expect to generate revenues by offering EAS through a Software as a Service (“SaaS”) model, which can be considered the AV software component of Robotics as a Service (“RaaS”).

RaaS is a subscription model that allows customers to use robots/vehicles without necessarily purchasing the hardware assets upfront. We will seek to achieve sustained revenue growth largely from ongoing SaaS-style EAS subscriptions that enable companies to tap into our ever-expanding suite of AV and AI capabilities as organizations transition into full industrial autonomy.

Although both the components and the combined solutions of EAS are still under development, EAS has already been used for a paid customer deployment as well as for paid trial and pilot deployments. We have not yet derived any significant recurring revenues from EAS but began marketing EAS to customers in 2022 with our first commercial deployment commencing in the first quarter of 2023. We expect EAS to continually be developed and enhanced according to evolving customer needs, which will take place concurrently while other completed features of EAS are commercialized. We expect annual R&D expenditures in the foreseeable future to exceed that of 2023. We also had limited paid deployments in 2023 which offset some of the ongoing R&D costs of continually developing EAS. We target scaled deployments to begin in the second half of 2024.

Our go-to-market strategy is to acquire new customers that use industrial vehicles in their mission-critical and daily operations by (a) leveraging the relationships and existing customers of our network of strategic partners, (b) bringing AV capabilities to industrial vehicles as a software service provider, and (c) executing a robust in-house sales and marketing effort to nurture a pipeline of industrial organizations. Our focus is on acquiring new customers who are either looking (a) to embed our technology into their vehicle product roadmaps or (b) to apply autonomy to existing fleets with our vehicle retrofits. In turn, our customers are any organizations that could utilize our EAS solution, including original equipment manufacturers (“OEMs”) that supply industrial vehicles, end customers that operate their own industrial vehicles, or service providers that operate industrial vehicles for end customers.

As OEMs and leading industrial vehicle users seek to increase productivity, reinforce safer working environments, and scale their operations, we believe we are uniquely positioned to deliver a dynamic autonomy solution via our EAS to a wide variety of industrial uses. Our long-term vision is for EAS to become a universal autonomous driving solution with minimal marginal cost for companies to adopt new vehicles and expand their autonomous fleets across new deployments. We have already deployed DriveMod software on more than 10 different vehicle form factors that range from stockchasers and forklifts to 14-seat shuttles and 5-meter-long cargo vehicles, demonstrating the extensibility of our AV building blocks.

Our strategy upon establishing a customer relationship with an OEM is to seek to embed our technology into their vehicle roadmap and expand our services to their clients. Once we solidify an initial AV deployment with a customer, we intend to expand within the site to additional vehicle platforms and/or expand the use of similar vehicles to other sites operated by the customer. This “land and expand” strategy can repeat iteratively across new vehicles and sites and is at the heart of why we believe industrial AVs that operate in constrained environments are poised to create value.

Critical Accounting Policies and Estimates and Judgements

Our condensed consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States and SEC regulations. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets and liabilities, disclosure of contingent liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. We continually evaluate our estimates and judgments. We base our estimates and judgments on historical experience and other factors that we believe to be reasonable under the circumstances. Materially different results can occur as circumstances change and additional information becomes known. Besides the estimates identified below that are considered critical, we make many other accounting estimates in preparing our financial statements and related disclosures. All estimates, whether or not deemed critical, affect reported amounts of assets, liabilities, revenues and expenses, as well as disclosures of contingent liabilities. These estimates and judgments are also based on historical experience and other factors that are believed to be reasonable under the circumstances. Materially different results can occur as circumstances change and additional information becomes known, even for estimates and judgments that are not deemed critical.

The Company considers capitalized software, warrants and share-based compensation to be critical accounting estimates and believes the associated assumptions and estimates will have the greatest potential impact on our condensed consolidated financial statements.

Costs to Develop Software

The Company incurs costs related to software internally developed. Based on the nature of the software the Company capitalizes software costs under the following guidance.

Internal-Use Software

The Company capitalizes certain costs related to internal-use software, primarily consisting of direct labor and third-party vendor costs associated with creating the software. Software development projects generally include three stages: the preliminary project stage (all costs are expensed as incurred), the application development stage (certain costs are capitalized and certain costs are expensed as incurred) and the post-implementation/operation stage (all costs are expensed as incurred). Costs capitalized in the application development stage include costs related to the design and implementation of the selected software components, software build and configuration infrastructure, and software interfaces. Capitalization of costs requires judgment in determining when a project has reached the application development stage, the proportion of time spent in the application development stage, and the period over which the Company expect to benefit from the use of that software. Once the software is placed in service, these costs are amortized on the straight-line method over the estimated useful life of the software, which is generally three to five years. There is judgment involved in the determination of the useful life. Internal-use software is classified as property and equipment in accordance with ASC 350, “Intangibles – Goodwill and Other”.

Costs to develop software to be sold, leased or otherwise marketed

The Company accounts for research costs of computer software to be sold, leased or otherwise marketed as expense until technological feasibility has been established for the product. Once technological feasibility is established, all software costs are capitalized until the product is available for general release to customers. Judgment is required in determining when technological feasibility of a product is established. We have determined that technological feasibility for our software products is reached shortly after a working prototype is complete and meets or exceeds design specifications including functions, features, and technical performance requirements. After technological feasibility is established, judgement is required to determine the amount of payroll and stock-based compensation costs to be capitalized on the remaining development efforts. These costs will continue to be capitalized until such time as when the product or enhancement is available for general release to customers. Computer software to be sold, leased or otherwise marketed is classified as an intangible asset in accordance with ASC 985, “Software”.

Common Stock Warrants

The Company issued to its lead underwriter in the Company’s initial public offering consummated in October 2021, (the “IPO”) warrants to purchase up to 140,000 shares of its common stock, exercisable at a price per share of $9.373 and expiring on October 19, 2026. Additionally, in connection with the Private Placement offering completed on April 29, 2022, the Company issued warrants to purchase 7,096,776 shares of its common stock, exercisable at a price per share of $2.71 and expiring on April 29, 2027. The Company accounts for warrants in accordance with ASC 480, “Distinguishing Liabilities from Equity”, depending on the specific terms of the warrant agreement. The Company determined the fair value of the warrants using the Black-Scholes pricing model and treated the warrants as equity instruments in consideration of the cashless settlement provisions in the warrant agreement.

Stock-based Compensation

The Company recognizes the cost of share-based awards granted to employees and directors based on the estimated grant-date fair value of the awards. Cost is recognized on a straight-line basis over the service period, which is generally the vesting period of the award. The Company recognizes stock-based compensation cost and reverses previously recognized costs for unvested awards in the period forfeitures occur. The Company determines the fair value of stock options using the Black-Scholes option pricing model, which is impacted by the fair value of common stock, expected price volatility of common stock, expected term, risk-free interest rates, and expected dividend yield.

Results of Operations

Revenue

We currently derive revenue from four sources. We enter into fixed-price NRE contracts related to trial projects that consist of several independent phases and include design, data gathering, hardware installation on an industrial vehicle, customer-specific configuration of the DriveMod software, and demonstrations. The determination of the contract price is based on labor and hardware costs estimated to achieve the required milestones specified in the contract. The purpose of these fully funded projects is to exhibit the feasibility of the Company’s technology offering to the customer on additional vehicle types and provide a level of confidence to encourage the customer to enter into a multi-year, commercial arrangement with the Company in the future. Revenue on these multi-phase contracts is generally recognized at the point in time when the performance obligations of each independent phase have been completed and customer acceptance has been acknowledged. Contracts often allow mutual termination without penalty. To the extent our actual costs vary from the fixed fee, we will generate more or less profit or could incur a loss.

In addition, we derive revenue from EAS subscriptions with relative add-on offerings such as hardware revenue and other revenue (i.e., deployment/set up costs). Revenue from these subscriptions and add-ons are recognized monthly over the service contract life, beginning at the time that a customer acknowledges acceptance of the service.

During the three months ended March 31, 2024, the Company recognized $5,513 of revenue, substantially all related to EAS subscriptions and hardware revenue.

Cost of Revenue

Cost of revenues consists primarily of direct labor and related fringe benefits for internal engineering resources costs incurred for the completion of the contracts and hardware costs.

During the three months ended March 31, 2024, the Company reported cost of revenue of $113,776 consisting primarily of deployment costs, related to personnel costs, travel expenses and associated hardware costs to specific customers.

Research and Development

Research and development expense consist primarily of outsourced engineering services, internal engineering and development expenses, materials, labor and stock-based compensation related to development of the Company’s products and services. Research and development costs incurred during NRE projects are capitalized and expensed when the associated NRE revenue is recognized. All other research and development costs are expensed as incurred.

Research and development expense for the three months ended March 31, 2024 increased by approximately $0.1 million or 3% to $3.1 million from approximately $3.0 million for the three months ended March 31, 2023. The increase is primarily attributable to the increase in personnel engaged in the research and development of our AV technology in 2024 compared to headcount levels in 2023, including provisions for non-cash stock-based compensation expense. The Company plans to expand its level of engineering and other R&D personnel to support its research and development efforts and expects research and development costs to increase over time.

General and Administrative

General and administrative expense consist primarily of personnel costs, facilities expenses, depreciation and amortization, travel, and advertising costs.

General and administrative expenses decreased by approximately $0.4 million or 12.9% to approximately $2.7 million for the three months ended March 31, 2024 from approximately $3.1 million for the three months ended March 31, 2023. The decrease was attributed to a decrease in personnel related costs, including provisions for non-cash stock-based compensation expense, as well as decreases in insurance, legal and professional fees and other general and administrative expenses.

Interest income

Interest income decreased by $45,575 to $1,327 for the three months ended March 31, 2024 from $46,902 for the three months ended March 31, 2023. Interest income consists primarily of interest earned of $24,638 from the Company’s interest-bearing bank accounts offset by interest expense of 23,311 related to the office lease.

Other Income (expense), net

Other income decreased by $174,257 to $(5,047) for the three months ended March 31, 2024 from $169,210 for the three months ended March 31, 2023. Other income consists primarily of realized gains earned on the Company’s short-term investments of $47,676 and the impairment charge of $52,723 related to expired international patents.

Liquidity and Capital Resources

The Company’s principal source of liquidity is its cash and current maturities of short-term investments. Short-term investments consist of placements in U.S. government securities with original maturities between three to nine months. As of March 31, 2024, the Company had unrestricted cash of approximately $2.2 million and short-term investments of approximately $2.6 million. As of December 31, 2023, the Company had unrestricted cash of approximately $3.6 million and short-term investments of approximately $4.6 million.

On May 31, 2023, the Company entered into an ATM Sales Agreement with Virtu Americas LLC (the “ATM Sales Agreement”), under which the Company may, from time to time, sell shares of the Company’s common stock at market prices by methods deemed to be an “at-the-market offering” as defined in Rule 415 promulgated under the Securities Act of 1933, as amended. The ATM Sales Agreement and related prospectus is limited to sales of up to an aggregate maximum of $8.8 million of shares of the Company’s common stock. The Company pays Virtu Americas LLC up to 3.0% of the gross proceeds as a commission. As of March 31, 2024, a total of 17,034,205 shares of common stock were sold through Virtu Americas LLC under the ATM Sales Agreement for net proceeds of $4,460,639 after payment of commission fees of $91,033 and other related expenses of $60,465. As of March 31, 2024, the Company had $4,222,297 million of common stock remaining available for sale under the ATM Sales Agreement.

On December 8, 2023, the Company entered into a Placement Agent Agreement with Aegis Capital Corp. (“Aegis”), pursuant to which Aegis acted as the Company’s placement agent, on a reasonable best efforts basis, in connection with the sale by the Company of an aggregate of 33,333,333 shares of common stock in a public offering, which included: (i) 11,466,733 shares of Common Stock, and (ii) pre-funded warrants to purchase 21,866,600 shares of Common Stock. The public offering closed on December 12, 2023. The Company received gross proceeds of approximately $5 million before deducting transaction related expenses payable by the Company. All commissions, qualified legal, accounting, registration and other direct costs of $0.5 million related to the public offering were offset against the gross proceeds.

The Company’s liquidity is based on its ability to enhance its operating cash flow position, obtain capital financing from equity interest investors and borrow funds to fund its general operations, research and development activities and capital expenditures. The Company’s ability to continue as a going concern is dependent on management’s ability to successfully execute its business plan, which includes increasing revenue while controlling operating costs and expenses and obtaining funds from outside sources of financing to generate positive financing cash flows.

Based on cash flow projections from operating and financing activities and the existing balance of cash and short-term investments, management is of the opinion that the Company has insufficient funds for sustainable operations, and it may not be able to meet its payment obligations from operations and related commitments, if the Company is not able to complete the required funding transactions to allow the Company to continue as a going concern for the next year. Based on these factors, the Company has substantial doubt it will continue as a going concern for the 12 months following the date that these interim financial statements were issued. These condensed consolidated financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets and liabilities that may result in the Company not being able to continue as a going concern.

Cash Flows

Operating activities

Net cash used in operating activities for the three months ended March 31, 2024 was approximately $5.8 million, an increase of approximately $0.4 million or 8% compared to approximately $5.4 million for the three months ended March 31, 2023. The increase is primarily attributed to the level of increases in personnel costs and professional services related to the Company’s research and development activities as the Company continues to grow, which led to the increase in the Company’s net loss for the period.

Investing activities

Net cash provided by investing activities for the three months ended March 31, 2024 was approximately $1.8 million, an decrease of approximately $1.0 million compared to net cash used in investing activities of approximately $2.8 million for the three months ended March 31, 2023. The decrease consists of smaller investment maturities of $3.8 million, which were offset by purchases of short-term investments of approximately $1.8 million and approximately $0.3 million in purchases of R&D-related hardware equipment, acquisition of intangible asset and capitalization of software.

Financing activities

Cash provided by financing activities for the three months ended March 31, 2024 was $2.7 million, which consisted of proceeds from the sale of common stock. Cash provided by financing activities for the three months ended March 31, 2023 was approximately $6.8 thousand, which consisted of proceeds from the exercise of stock options.

Emerging Growth Company Status

We are an “emerging-growth company”, as defined in the JOBS Act, and, for as long as we continue to be an emerging growth company, we may choose to take advantage of exemptions from various reporting requirements applicable to other public companies but not to emerging growth companies, including, but not limited to, not being required to have our independent registered public accounting firm audit our internal control over financial reporting under Section 404 of the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not previously approved. As an emerging growth company we can also delay adopting new or revised accounting standards until such time as those standards apply to private companies. We intend to avail ourselves of these options. Once adopted, we must continue to report on that basis until we no longer qualify as an emerging growth company.

We will cease to be an emerging growth company upon the earliest of: (i) the end of the fiscal year following the fifth anniversary of the initial public offering; (ii) the first fiscal year after our annual gross revenue are $1.07 billion or more; (iii) the date on which we have, during the previous three-year period, issued more than $1.0 billion in non-convertible debt securities; or (iv) the end of any fiscal year in which the market value of our common stock held by non-affiliates exceeded $700 million as of the end of the second quarter of that fiscal year. We cannot predict if investors will find our common stock less attractive if we choose to rely on these exemptions. If, as a result of our decision to reduce future disclosure, investors find our common shares less attractive, there may be a less active trading market for our common shares and the price of our common shares may be more volatile.

We are also a “smaller reporting company”, meaning that the market value of our stock held by non-affiliates plus the aggregate amount of gross proceeds to us as a result of the IPO is less than $700 million and our annual revenue was less than $100 million during the most recently completed fiscal year. We may continue to be a smaller reporting company if either (i) the market value of our stock held by non-affiliates is less than $250 million or (ii) our annual revenue was less than $100 million during the most recently completed fiscal year and the market value of our stock held by non-affiliates is less than $700 million. If we are a smaller reporting company at the time we cease to be an emerging growth company, we may continue to rely on exemptions from certain disclosure requirements that are available to smaller reporting companies. Specifically, as a smaller reporting company we may choose to present only the two most recent fiscal years of audited financial statements in our Annual Report on Form 10-K and, similar to emerging growth companies, smaller reporting companies have reduced disclosure obligations regarding executive compensation.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

Not required for smaller reporting companies.

ITEM 4. CONTROLS AND PROCEDURES

Management’s Report on Disclosure Controls and Procedures

Our management, under the supervision and with the participation of our Principal Executive Officer (our Chief Executive Officer) and Principal Financial Officer (our Chief Financial Officer), has evaluated the effectiveness of our disclosure controls and procedures as of March 31, 2024. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended, or the Exchange Act, means controls and other procedures of a company that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the Securities and Exchange Commission’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is accumulated and communicated to the company’s management, including its principal executive and principal financial officers, or person performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

Management recognizes that any disclosure controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives, and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. Based on the evaluation of our disclosure controls and procedures as of March 31, 2024, our Chief Executive Officer and Chief Financial Officer have concluded that, as of such date, our disclosure controls and procedures are effective.

Changes in Internal Control over Financial Reporting

There has been no change in our internal control over financial reporting during the quarter ended March 31, 2024 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II — OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS

We are not currently a party to any material legal proceedings. From time to time, we may become involved in legal proceedings arising in the ordinary course of our business. Regardless of outcome, litigation can have an adverse impact on us due to defense and settlement costs, diversion of management resources, negative publicity, reputational harm and other factors.

ITEM 1A. RISK FACTORS

Factors that could cause our actual results to differ materially from those in this Quarterly Report are any of the risks described in “Part I, Item 1A. Risk Factors” in the Form 10-K. Any of these factors could result in a significant or material adverse effect on our results of operations or financial condition. Additional risk factors not presently known to us or that we currently deem immaterial may also impair our business or results of operations.

As of the date of this Quarterly Report, there were no material changes to the risks and uncertainties described in the section titled “Risk Factors” in the Form 10-K during the three months ended March 31, 2024.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

None.

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

None.

ITEM 4. MINE SAFETY DISCLOSURES

Not applicable.

ITEM 5. OTHER INFORMATION

Rule 10b5-1 Trading Arrangement

During the three months ended March 31, 2024, no director or officer of the Company adopted or terminated a “Rule 10b5-1 trading arrangement” or “non-Rule 10b5-1 trading arrangement,” as each term is defined in Item 408(a) of Regulation S-K.

ITEM 6. EXHIBITS

Exhibit Number		Description
31.1*		Certification of Principal Executive Officer pursuant to Rules 13a-14(a) and 15d-14(a) of the Securities Exchange Act, as amended.
31.2*		Certification of Principal Financial Officer pursuant to Rules 13a-14(a) and 15d-14(a) of the Securities Exchange Act, as amended.
32.1**		Certification of Principal Executive Officer and Principal Financial Officer pursuant to Rules 13a-14(b) or 15d-14(b) of the Securities Exchange Act, as amended, and 18 U.S.C. Section 1350.
101.INS		Inline XBRL Instance Document
101.SCH		Inline XBRL Taxonomy Extension Schema Document.
101.CAL		Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF		Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB		Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE		Inline XBRL Taxonomy Extension Presentation Linkbase Document.
104		Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101).

*	Filed herewith.
**	Furnished herewith.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized, on this 9^th day of May, 2024.

	CYNGN INC.

	/s/ Lior Tal
	Lior Tal
	Chief Executive Officer, Chairman of the Board of Directors and Director
	(Principal Executive Officer)

	/s/ Donald Alvarez
	Donald Alvarez
	Chief Financial Officer
	(Principal Financial and Accounting Officer)

0.08 0.15 37685413 77081105 37685413 77081105 0.08 0.15 false --12-31 Q1 0001874097 0001874097 2024-01-01 2024-03-31 0001874097 2024-05-08 0001874097 2024-03-31 0001874097 2023-12-31 0001874097 2023-01-01 2023-03-31 0001874097 us-gaap:PreferredStockMember 2022-12-31 0001874097 us-gaap:CommonStockMember 2022-12-31 0001874097 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001874097 us-gaap:RetainedEarningsMember 2022-12-31 0001874097 2022-12-31 0001874097 us-gaap:PreferredStockMember 2023-01-01 2023-03-31 0001874097 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001874097 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001874097 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001874097 us-gaap:PreferredStockMember 2023-03-31 0001874097 us-gaap:CommonStockMember 2023-03-31 0001874097 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001874097 us-gaap:RetainedEarningsMember 2023-03-31 0001874097 2023-03-31 0001874097 us-gaap:PreferredStockMember 2023-12-31 0001874097 us-gaap:CommonStockMember 2023-12-31 0001874097 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001874097 us-gaap:RetainedEarningsMember 2023-12-31 0001874097 us-gaap:PreferredStockMember 2024-01-01 2024-03-31 0001874097 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001874097 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001874097 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001874097 us-gaap:PreferredStockMember 2024-03-31 0001874097 us-gaap:CommonStockMember 2024-03-31 0001874097 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001874097 us-gaap:RetainedEarningsMember 2024-03-31 0001874097 srt:MaximumMember 2024-01-01 2024-03-31 0001874097 srt:MinimumMember 2023-01-01 2023-03-31 0001874097 srt:MinimumMember 2024-03-31 0001874097 srt:MaximumMember 2024-03-31 0001874097 2022-04-01 2022-04-01 0001874097 2022-04-01 0001874097 us-gaap:IntellectualPropertyMember 2023-12-31 2023-12-31 0001874097 us-gaap:IPOMember 2024-03-31 0001874097 srt:ChiefExecutiveOfficerMember 2023-01-01 2023-12-31 0001874097 cyngn:SubscriptionMember 2024-01-01 2024-03-31 0001874097 cyngn:SubscriptionMember 2023-01-01 2023-03-31 0001874097 cyngn:NonRecurringEngineeringMember 2024-01-01 2024-03-31 0001874097 cyngn:NonRecurringEngineeringMember 2023-01-01 2023-03-31 0001874097 cyngn:HardwareMember 2024-01-01 2024-03-31 0001874097 cyngn:HardwareMember 2023-01-01 2023-03-31 0001874097 srt:MinimumMember us-gaap:SoftwareDevelopmentMember 2024-03-31 0001874097 srt:MaximumMember us-gaap:SoftwareDevelopmentMember 2024-03-31 0001874097 sic:Z3570 2024-03-31 0001874097 us-gaap:FurnitureAndFixturesMember 2024-03-31 0001874097 us-gaap:LeaseholdImprovementsMember 2024-03-31 0001874097 us-gaap:VehiclesMember 2024-03-31 0001874097 cyngn:CustomerAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0001874097 cyngn:CustomerAMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0001874097 cyngn:CustomerBMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2024-01-01 2024-03-31 0001874097 cyngn:CustomerBMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2023-01-01 2023-03-31 0001874097 us-gaap:VehiclesMember 2023-12-31 0001874097 us-gaap:FurnitureAndFixturesMember 2023-12-31 0001874097 us-gaap:ComputerEquipmentMember 2024-03-31 0001874097 us-gaap:ComputerEquipmentMember 2023-12-31 0001874097 us-gaap:SoftwareDevelopmentMember 2024-03-31 0001874097 us-gaap:SoftwareDevelopmentMember 2023-12-31 0001874097 us-gaap:LeaseholdImprovementsMember 2023-12-31 0001874097 us-gaap:ConstructionInProgressMember 2024-03-31 0001874097 us-gaap:ConstructionInProgressMember 2023-12-31 0001874097 cyngn:AbandonedInventoryMember 2024-01-01 2024-03-31 0001874097 2023-01-01 2023-12-31 0001874097 us-gaap:ComputerSoftwareIntangibleAssetMember cyngn:GrossCarryingAmountMember 2024-03-31 0001874097 us-gaap:ComputerSoftwareIntangibleAssetMember cyngn:AccumulatedAmortizationMember 2024-03-31 0001874097 us-gaap:ComputerSoftwareIntangibleAssetMember cyngn:ImpairmentMember 2024-01-01 2024-03-31 0001874097 us-gaap:ComputerSoftwareIntangibleAssetMember cyngn:NetCarryingAmountMember 2024-03-31 0001874097 us-gaap:PatentsMember cyngn:GrossCarryingAmountMember 2024-03-31 0001874097 us-gaap:PatentsMember cyngn:AccumulatedAmortizationMember 2024-03-31 0001874097 us-gaap:PatentsMember cyngn:ImpairmentMember 2024-01-01 2024-03-31 0001874097 us-gaap:PatentsMember cyngn:NetCarryingAmountMember 2024-03-31 0001874097 us-gaap:TrademarksMember cyngn:GrossCarryingAmountMember 2024-03-31 0001874097 us-gaap:TrademarksMember cyngn:AccumulatedAmortizationMember 2024-03-31 0001874097 us-gaap:TrademarksMember cyngn:ImpairmentMember 2024-01-01 2024-03-31 0001874097 us-gaap:TrademarksMember cyngn:NetCarryingAmountMember 2024-03-31 0001874097 cyngn:GrossCarryingAmountMember 2024-03-31 0001874097 cyngn:AccumulatedAmortizationMember 2024-03-31 0001874097 cyngn:ImpairmentMember 2024-01-01 2024-03-31 0001874097 cyngn:NetCarryingAmountMember 2024-03-31 0001874097 us-gaap:ComputerSoftwareIntangibleAssetMember cyngn:GrossCarryingAmountMember 2023-12-31 0001874097 us-gaap:ComputerSoftwareIntangibleAssetMember cyngn:AccumulatedAmortizationMember 2023-12-31 0001874097 us-gaap:ComputerSoftwareIntangibleAssetMember cyngn:FairMarketValueAdjustmentMember 2023-01-01 2023-12-31 0001874097 us-gaap:ComputerSoftwareIntangibleAssetMember cyngn:ImpairmentMember 2023-01-01 2023-12-31 0001874097 us-gaap:ComputerSoftwareIntangibleAssetMember cyngn:NetCarryingAmountMember 2023-12-31 0001874097 us-gaap:PatentsMember cyngn:GrossCarryingAmountMember 2023-12-31 0001874097 us-gaap:PatentsMember cyngn:AccumulatedAmortizationMember 2023-12-31 0001874097 us-gaap:PatentsMember cyngn:FairMarketValueAdjustmentMember 2023-01-01 2023-12-31 0001874097 us-gaap:PatentsMember cyngn:ImpairmentMember 2023-01-01 2023-12-31 0001874097 us-gaap:PatentsMember cyngn:NetCarryingAmountMember 2023-12-31 0001874097 us-gaap:TrademarksMember cyngn:GrossCarryingAmountMember 2023-12-31 0001874097 us-gaap:TrademarksMember cyngn:AccumulatedAmortizationMember 2023-12-31 0001874097 us-gaap:TrademarksMember cyngn:FairMarketValueAdjustmentMember 2023-01-01 2023-12-31 0001874097 us-gaap:TrademarksMember cyngn:ImpairmentMember 2023-01-01 2023-12-31 0001874097 us-gaap:TrademarksMember cyngn:NetCarryingAmountMember 2023-12-31 0001874097 us-gaap:IntellectualPropertyMember cyngn:GrossCarryingAmountMember 2023-12-31 0001874097 us-gaap:IntellectualPropertyMember cyngn:AccumulatedAmortizationMember 2023-12-31 0001874097 us-gaap:IntellectualPropertyMember cyngn:FairMarketValueAdjustmentMember 2023-01-01 2023-12-31 0001874097 us-gaap:IntellectualPropertyMember cyngn:ImpairmentMember 2023-01-01 2023-12-31 0001874097 us-gaap:IntellectualPropertyMember cyngn:NetCarryingAmountMember 2023-12-31 0001874097 cyngn:GrossCarryingAmountMember 2023-12-31 0001874097 cyngn:AccumulatedAmortizationMember 2023-12-31 0001874097 cyngn:FairMarketValueAdjustmentMember 2023-01-01 2023-12-31 0001874097 cyngn:ImpairmentMember 2023-01-01 2023-12-31 0001874097 cyngn:NetCarryingAmountMember 2023-12-31 0001874097 us-gaap:CommonStockMember 2024-03-31 0001874097 us-gaap:CommonStockMember 2023-12-31 0001874097 us-gaap:ConvertiblePreferredStockMember 2021-10-31 0001874097 cyngn:PreferredStockIssuedMember 2024-03-31 0001874097 cyngn:PreferredStockOutstandingMember 2023-12-31 0001874097 2023-12-08 0001874097 us-gaap:CommonStockMember 2023-12-08 0001874097 cyngn:PreFundedWarrantsMember 2023-12-08 0001874097 cyngn:ATMSalesAgreementMember 2023-05-31 0001874097 2023-05-31 2023-05-31 0001874097 cyngn:PurchaseWarrantsMember 2024-01-01 2024-03-31 0001874097 cyngn:PreFundedWarrantsMember 2022-05-01 2022-05-31 0001874097 us-gaap:PrivatePlacementMember 2024-03-31 0001874097 2023-01-29 2023-01-29 0001874097 us-gaap:WarrantMember us-gaap:CommonStockMember us-gaap:IPOMember 2024-03-31 0001874097 us-gaap:WarrantMember us-gaap:CommonStockMember us-gaap:IPOMember 2024-01-01 2024-03-31 0001874097 us-gaap:WarrantMember us-gaap:CommonStockMember us-gaap:PrivatePlacementMember 2024-03-31 0001874097 us-gaap:WarrantMember us-gaap:CommonStockMember us-gaap:PrivatePlacementMember 2024-01-01 2024-03-31 0001874097 us-gaap:WarrantMember 2024-03-31 0001874097 us-gaap:WarrantMember 2024-01-01 2024-03-31 0001874097 cyngn:InitialPublicOfferingWarrantsMember 2024-03-31 0001874097 cyngn:PrivatePlacementWarrantsMember 2024-03-31 0001874097 cyngn:InitialPublicOfferingWarrantsMember 2024-01-01 2024-03-31 0001874097 cyngn:PrivatePlacementWarrantsMember 2024-01-01 2024-03-31 0001874097 2023-10-23 2023-10-30 0001874097 2023-11-07 0001874097 2023-11-07 2023-11-07 0001874097 2023-12-31 2023-12-31 0001874097 us-gaap:RestrictedStockUnitsRSUMember 2023-12-31 0001874097 us-gaap:RestrictedStockUnitsRSUMember 2024-01-01 2024-03-31 0001874097 us-gaap:RestrictedStockUnitsRSUMember 2024-03-31 0001874097 cyngn:NasdaqComplianceMember 2023-08-24 0001874097 cyngn:RegainComplianceMember 2023-08-24 0001874097 2024-05-08 2024-05-08 0001874097 us-gaap:SubsequentEventMember 2024-04-23 2024-04-23 0001874097 us-gaap:SubsequentEventMember 2024-04-23 0001874097 us-gaap:WarrantMember us-gaap:SubsequentEventMember 2024-04-23 2024-04-23 0001874097 us-gaap:SubsequentEventMember us-gaap:OverAllotmentOptionMember 2024-05-03 xbrli:shares iso4217:USD iso4217:USD xbrli:shares xbrli:pure

Exhibit 31.1

CERTIFICATIONS OF CHIEF EXECUTIVE OFFICER

PURSUANT TO RULES 13A-14 AND 15D-14

OF THE SECURITIES EXCHANGE ACT OF 1934

I, Lior Tal, certify that:

1)	I have reviewed this quarterly report on Form 10-Q of Cyngn Inc.;

2)	Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

3)	Based on my knowledge, the financial statements and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

4)	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

	a.	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared.

	b.	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

	c.	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this quarterly report based on such evaluation; and

	d.	Disclosed in this quarterly report any changes in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5)	The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

	a.	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

	b.	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 9, 2024

	/s/ Lior Tal
	Lior Tal
	Chief Executive Officer
	(Principal Executive Officer)

Exhibit 31.2

CERTIFICATIONS OF CHIEF FINANCIAL OFFICER

PURSUANT TO RULES 13A-14 AND 15D-14

OF THE SECURITIES EXCHANGE ACT OF 1934

I, Donald Alvarez, certify that:

1)	I have reviewed this quarterly report on Form 10-Q of Cyngn Inc.;

2)	Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this quarterly report;

3)	Based on my knowledge, the financial statements and other financial information included in this quarterly report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this quarterly report;

4)	The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

	a.	Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this quarterly report is being prepared.

	b.	Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

	c.	Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this quarterly report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this quarterly report based on such evaluation; and

	d.	Disclosed in this quarterly report any changes in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5)	The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of registrant’s board of directors (or persons performing the equivalent functions):

	a.	All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

	b.	Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

Date: May 9, 2024

	/s/ Donald Alvarez
	Donald Alvarez
	Chief Financial Officer
	(Principal Financial and Accounting Officer)

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Cyngn Inc. (“Company”) on Form 10-Q for the quarter ended March 31, 2024, as filed with the Securities and Exchange Commission on the date hereof (“Report”), the undersigned, in the capacities and on the date indicated below, each hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the knowledge of each of the undersigned:

1)	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

2)	The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: May 9, 2024

	/s/ Lior Tal
	Lior Tal
	Chief Executive Officer (Principal Executive Officer)

	/s/ Donald Alvarez
	Donald Alvarez Chief Financial Officer (Principal Financial and Accounting Officer)

Cover - shares	3 Months Ended
Cover - shares	Mar. 31, 2024	May 08, 2024
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Transition Report	false
Entity Interactive Data Current	Yes
Amendment Flag	false
Document Period End Date	Mar. 31, 2024
Document Fiscal Year Focus	2024
Document Fiscal Period Focus	Q1
Entity Information [Line Items]
Entity Registrant Name	CYNGN INC.
Entity Central Index Key	0001874097
Entity File Number	001-40932
Entity Tax Identification Number	46-2007094
Entity Incorporation, State or Country Code	DE
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Shell Company	false
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Contact Personnel [Line Items]
Entity Address, Address Line One	1015 O’Brien Dr
Entity Address, City or Town	Menlo Park
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94025
Entity Phone Fax Numbers [Line Items]
City Area Code	(650)
Local Phone Number	924-5905
Entity Listings [Line Items]
Title of 12(b) Security	Common stock, $0.00001
Trading Symbol	CYN
Security Exchange Name	NASDAQ
Entity Common Stock, Shares Outstanding		141,542,715

Condensed Consolidated Balance Sheets - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Current assets
Cash	$ 2,192,398	$ 3,591,623
Short-term investments	2,578,882	4,561,928
Prepaid expenses and other current assets	1,502,115	1,316,426
Total current assets	6,273,395	9,469,977
Property and equipment, net	1,652,382	1,486,672
Right of use asset, net	821,144	992,292
Intangible assets, net	1,045,412	1,084,415
Total Assets	9,792,333	13,033,356
Current liabilities
Accounts payable	248,677	196,963
Accrued expenses and other current liabilities	720,239	1,201,142
Current operating lease liability	724,654	682,718
Total current liabilities	1,693,570	2,080,823
Non-current operating lease liability	127,572	317,344
Total liabilities	1,821,142	2,398,167
Commitments and contingencies (Note 12)
Stockholders’ Equity
Preferred stock, Par $0.00001, 10 million shares authorized; no shares issued and outstanding as of March 31, 2024 and December 31, 2023
Common stock, Par $0.00001; 200,000,000 shares authorized, 88,454,654 and 64,773,756 shares issued and outstanding as of March 31, 2024 and December 31, 2023, respectively	884	648
Additional paid-in capital	173,958,005	170,652,160
Accumulated deficit	(165,987,698)	(160,017,619)
Total stockholders’ equity	7,971,191	10,635,189
Total Liabilities and Stockholders’ Equity	$ 9,792,333	$ 13,033,356

Condensed Consolidated Balance Sheets (Parentheticals) - $ / shares	Mar. 31, 2024	Dec. 31, 2023
Statement of Financial Position [Abstract]
Preferred stock, par value (in Dollars per share)	$ 0.00001	$ 0.00001
Preferred stock, shares authorized	10,000,000	10,000,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value (in Dollars per share)	$ 0.00001	$ 0.00001
Common stock, shares authorized	200,000,000	200,000,000
Common stock, shares issued	88,454,654	64,773,756
Common stock, shares outstanding	88,454,654	64,773,756

Condensed Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Revenue	$ 5,513	$ 872,800
Costs and expenses
Cost of revenue	113,776	616,694
Research and development	3,154,695	3,030,056
General and administrative	2,703,401	3,070,920
Total costs and expenses	5,971,872	6,717,670
Loss from operations	(5,966,359)	(5,844,870)
Other income, net
Interest income	1,327	46,902
Other income (expense), net	(5,047)	169,210
Total other income (expense), net	(3,720)	216,112
Net loss	$ (5,970,079)	$ (5,628,758)
Net loss per share attributable to common stockholders, basic (in Dollars per share)	$ (0.08)	$ (0.15)
Weighted-average shares used in computing net loss per share attributable to common stockholders, basic (in Shares)	77,081,105	37,685,413

Condensed Consolidated Statements of Operations (Unaudited) (Parentheticals) - $ / shares	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Income Statement [Abstract]
Net loss per share attributable to common stockholders, diluted	$ (0.08)	$ (0.15)
Weighted-average shares used in computing net loss per share attributable to common stockholders, diluted	77,081,105	37,685,413

Condensed Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($)	Common Stock	Additional Paid in Capital	Accumulated Deficit	Total
Balance at Dec. 31, 2022	$ 337	$ 159,847,229	$ (135,730,039)	$ 24,117,527
Balance (in Shares) at Dec. 31, 2022	33,684,864
Exercise of stock options and vesting of restricted stock units		6,844		6,844
Exercise of stock options and vesting of restricted stock units (in Shares)	34,728
Stock-based compensation		924,898		924,898
Net loss			(5,628,758)	(5,628,758)
Balance at Mar. 31, 2023	$ 337	160,778,972	(141,358,797)	19,420,512
Balance (in Shares) at Mar. 31, 2023	33,719,592
Balance at Dec. 31, 2023	$ 648	170,652,160	(160,017,619)	10,635,189
Balance (in Shares) at Dec. 31, 2023	64,773,756
Exercise of stock options and vesting of restricted stock units
Exercise of stock options and vesting of restricted stock units (in Shares)	12,228
Stock-based compensation		654,024		654,024
Issuance of common stock at-the-market equity financing, net of offering costs of $54,137	$ 133	2,651,977		2,652,110
Issuance of common stock at-the-market equity financing, net of offering costs of $54,137 (in Shares)	13,302,681
Issuance of common stock for pre-funded warrants in connection with the private placement offering, net of offering costs of $156.	$ 103	(156)		(53)
Issuance of common stock for pre-funded warrants in connection with the private placement offering, net of offering costs of $156. (in Shares)	10,365,989
Net loss			(5,970,079)	(5,970,079)
Balance at Mar. 31, 2024	$ 884	$ 173,958,005	$ (165,987,698)	$ 7,971,191
Balance (in Shares) at Mar. 31, 2024	88,454,654

Condensed Consolidated Statements of Stockholders’ Equity (Unaudited) (Parentheticals)	3 Months Ended
	Mar. 31, 2024 USD ($)
Statement of Stockholders' Equity [Abstract]
Issuance of common stock at-the-market equity financing, net of offering costs	$ 54,137
Stock dividend, net of offering costs	$ 156

Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Cash flows from operating activities
Net loss	$ (5,970,079)	$ (5,628,758)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	225,590	228,031
Stock-based compensation	654,024	924,898
Realized gain on short-term investments	(39,938)	(169,209)
Gain on asset	52,723
Prepaid expenses, operating lease right-of-use assets, and other current assets	(185,689)	(258,859)
Accounts payable	51,714	287,656
Accrued expenses, lease liabilities, and other current liabilities	(628,739)	(761,207)
Net cash used in operating activities	(5,840,394)	(5,377,448)
Cash flows from investing activities
Purchase of property and equipment	(214,238)	(447,739)
Acquisition of intangible asset	(19,634)	(44,745)
Purchase of short-term investments	(1,787,016)	(10,497,206)
Proceeds from maturity of short-term investments	3,810,000	13,742,000
Net cash provided by investing activities	1,789,112	2,752,310
Cash flows from financing activities
Proceeds from at-the-market equity financing, net of issuance costs	2,652,110
Issuance costs from public issuance of common stock and pre-funded warrants	(53)
Proceeds from exercise of stock options		6,844
Net cash provided by financing activities	2,652,057	6,844
Net decrease in cash	(1,399,225)	(2,618,294)
Cash, beginning of period	3,591,623	10,586,273
Cash, end of period	2,192,398	7,967,979
Supplemental disclosure of cash flow:
Cash paid during the period for interest and taxes
Supplemental disclosure of non-cash activities:
Acquisition of property and equipment included in accounts payable and accrued expenses	$ 27,552	$ 139,568

Description of Business

3 Months Ended

Mar. 31, 2024

Description of Business [Abstract]

Description of Business

1. Description of Business

Liquidity and Going Concern

Summary of Significant Accounting Policies

3 Months Ended

Mar. 31, 2024

Summary of Significant Accounting Policies [Abstract]

Summary of Significant Accounting Policies

2. Summary of Significant Accounting Policies

Basis of Presentation

Principles of Consolidation

Foreign Currency Translation

Use of Estimates

Concentration of Credit Risk

Concentration of Supplier Risk

Cash and Short-term Investments

Accounts Receivable

Fair Value Measurements

The Company uses the following fair value hierarchy prescribed by U.S. GAAP, which prioritizes the inputs used to measure fair value as follows:

Level 1—Unadjusted quoted prices in active markets for identical assets or liabilities.

Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

Property and Equipment

Property and Equipment		Useful life
Internal-use software		3 to 5 years
Computer and equipment		5 years
Furniture and fixtures		7 years
Leasehold improvements		Shorter of 3 years or lease term
Vehicles		5 years

Leases

Costs to Develop Software

The Company incurs costs related to internally developed software. Based on the nature of the software, the Company capitalizes software costs under the following guidance.

Internal-Use Software costs

Costs to Develop Software to be Sold, Leased or Otherwise Marketed

The Company accounts for research costs of computer software to be sold, leased or otherwise marketed as expense until technological feasibility has been established for the product. Once technological feasibility is established, certain payroll and stock compensation, occupancy, and professional service costs that are incurred to develop functionality for the Company’s software and internally built software platforms, as well as certain upgrades and enhancements that are expected to result in enhanced functionality are capitalized. Judgment is required in determining when technological feasibility of a product is established. Management has determined that technological feasibility is established when a working model is complete.

Long-Lived Assets and Finite Lived Intangibles

Income Taxes

Common Stock Warrants

Stock-based Compensation

Net Loss Per Share Attributable to Common Stockholders

Research and Development Expense

Selling, General, and Administrative Expense

Commitments

Segment Reporting

Revenue Recognition

Under ASC 606, “Revenue from Contracts with Customers”, the Company determines revenue recognition through the following steps:

●

Identifying the contract, or contracts, with the customer;

●

Identifying the performance obligations in the contract;

●

Determining the transaction price;

●

Allocating the transaction price to performance obligations in the contract; and

●

Recognizing revenue when, or as, the Company satisfies performance obligations by transferring the promised goods or services.

Subscription

For the three months ended March 31, 2024 and 2023, subscription revenue was $2,727 and $1,537, respectively.

Non-Recurring Engineering (“NRE”)

For the three months ended March 31, 2024 and 2023, NRE revenue was $0 and $870,000, respectively.

Hardware

For the three months ended March 31, 2024 and 2023, hardware revenue was $2,786 and $963, respectively.

Other:

For the three months ended March 31, 2024 and 2023, other revenue was $0 and $300, respectively.

Arrangements with Multiple Performance Obligations

Material Rights:

Other Policies, Judgments and Practical Expedients

elected the optional exemption, which allows for the exclusion of the amounts for remaining performance obligations that are part of contracts with an original expected duration of one year or less.

Principal vs. Agent Considerations

Concentration of Credit Risk

The following table sets forth the percentages of total revenue for customers that represents 10% or more of the respective amounts for the three months ended March 31, 2024 and 2023, respectively.

	2024			2023
Customer A		*			76.8	%
Customer B		100	%		*

Below 10%

There were no accounts receivable from these customers at March 31, 2024 and December 31, 2023.

Cost of Revenue

Cost of revenue consists primarily of direct labor and related fringe benefits for internal engineering resources costs incurred for the completion of the contracts and hardware costs.

Revenue and Contracts with Customers

3 Months Ended

Mar. 31, 2024

Revenue and Contracts with Customers [Abstract]

Revenue and Contracts with Customers

3. Revenue and Contracts with Customers

Contract Balances

Deferred Contract Costs

Balance Sheet Components

3 Months Ended

Mar. 31, 2024

Balance Sheet Components [Abstract]

Balance Sheet Components

4. Balance Sheet Components

Financial Instruments

Prepaid expenses and other current assets

Prepaid expenses and other current assets are comprised of the following:

	March 31, 2024		December 31, 2023
Inventory, net	$	70,280	$	-
Prepaid expenses		437,906		385,474
Security deposits		175,191		155,729
Tax receivables		763,624		765,697
Receivables and current assets		55,114		9,526
Total prepaid and expenses and other current assets	$	1,502,115	$	1,316,426

Property and Equipment, Net

Property and equipment is comprised of the following:

	March 31,			December 31,
	2024			2023
Automobiles	$	656,997		$	616,947
Furniture and fixtures		178,491			178,491
Computer and equipment		529,541			517,181
Capitalized software		444,115			342,136
Leasehold improvements		208,848			458,406
Construction work in progress		518,255			208,848
Property and equipment, gross		2,536,247			2,322,009
Less: accumulated depreciation		(883,865	)		(835,337	)
Total property and equipment, net	$	1,652,382		$	1,486,672

Depreciation expense for the three months ended March 31, 2024 and 2023 was $48,528 and $81,464, respectively.

Accounts Payable

Accounts payable includes independent director fees payable of $42,500 and $41,250 as of March 31, 2024 and December 31, 2023, respectively.

Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities are comprised of the following:

	March 31, 2024		December 31, 2023
Credit card payable	$	4,699	$	1,103
Accrued expenses		355,910		214,286
Accrued payroll		359,630		985,753
Total accrued expenses and other current liabilities	$	720,239	$	1,201,142

Operating Leases

3 Months Ended

Mar. 31, 2024

Operating Leases [Abstract]

Operating Leases

5. Operating Leases

Period	Operating Lease
Remainder of 2024	$	553,636
2025		320,526
Total lease payments		874,162
Less: imputed interest		(21,936	)
Present value of lease liability	$	852,226

	March 31,			December 31,
	2024			2023
Weighted-average remaining lease term (in years)		1.17			1.42
Weighted -average discount rate		3.60	%		3.05	%

Intangible Assets, Net

3 Months Ended

Mar. 31, 2024

Intangible Assets, Net [Abstract]

Intangible Assets, Net

6. Intangible Assets, Net

The gross carrying amount and accumulated amortization of separately identifiable intangible assets are as follows:

	As of March 31, 2024
	Gross Carrying Amount		Accumulated Amortization			Impairment			Net Carrying Amount
Developed software	$	542,692	$	-		$	-		$	542,692
Patents		559,474		(25,281	)		(52,723	)		481,470
Trademark		45,000		(23,750	)		-			21,250
Total intangible assets	$	1,147,166	$	(49,031	)	$	(52,723	)	$	1,045,412

	As of December 31, 2023
	Gross Carrying Amount		Accumulated Amortization			Fair Market Value Adjustment			Impairment			Net Carrying Amount
Developed software	$	542,692	$	-		$	-		$	-		$	542,692
Patents		539,840		(20,117	)		-			-			519,723
Trademark		45,000		(23,000	)		-			-			22,000
Rights to intellectual property		100,000		(20,000	)		(50,000	)		(30,000	)		-
Total intangible assets	$	1,227,532	$	(63,117	)	$	(50,000	)	$	(30,000	)	$	1,084,415

Amortization expense for each of the three months ended March 31, 2024 and 2023 was $5,914 and $8,547, respectively.

Estimated amortization expense for all intangible assets subject to amortization in future years is expected to be:

	Amortization
Remainder 2024	$	17,740
2025		23,654
2026		23,654
2027		23,654
2028		23,654
Thereafter		933,056
Total	$	1,045,412

Capital Structure

3 Months Ended

Mar. 31, 2024

Capital Structure [Abstract]

Capital Structure

7. Capital Structure

Common Stock

Preferred Stock

Common Stock Offering

At the Market Equity Financing

Private Placement Offering

Common Stock Warrants

Securities into which warrants are convertible	Warrants outstanding		Exercise Price		Expiration Date	Fair value
Common stock (Initial Public Offering)		140,000	$	9.375	October 2026	$	170,397
Common stock (Private Placement)		7,096,776	$	2.71	April 2027		6,745,681
Total		7,236,776				$	6,916,078

The Company used the following assumptions:

	Initial Public Offering Warrants			Private Placement Warrants
Fair value of underlying securities	$	2.88		$	1.37
Expected volatility		51.0	%		45.0	%
Expected term (in years)		5.0			5.0
Risk-free interest rate		1.13	%		2.92	%

Net Loss Per Share Attributable to Common Stockholders

3 Months Ended

Mar. 31, 2024

Net Loss Per Share Attributable to Common Stockholders [Abstract]

Net Loss Per Share Attributable to Common Stockholders

8. Net Loss Per Share Attributable to Common Stockholders

The following table summarizes the computation of basic and diluted loss per share:

	Three months Ended March 31,
	2024			2023
Net loss attributable to common stockholders	$	(5,970,079	)	$	(5,628,758	)

Basic and diluted weighted average common shares outstanding		77,081,105			37,685,413

Loss per share:
Basic and diluted	$	(0.08	)	$	(0.15	)

Stock-Based Compensation Expense

3 Months Ended

Mar. 31, 2024

Stock-Based Compensation Expense [Abstract]

Stock-based Compensation Expense

9. Stock-based Compensation Expense

Stock-Based Compensation

The assumptions and estimates for valuing stock options are as follows:

●

Risk-free interest rate. The risk-free interest rate is based on the U.S. Treasury yield curve in effect during the period the options were granted corresponding to the expected term of the awards.

●

Estimated dividend yield. The estimated dividend yield is zero, as the Company does not currently intend to declare dividends in the foreseeable future.

Equity Incentive Plans

As of March 31, 2024 and December 31, 2023, approximately 8.6 million and approximately 0.7 million shares of common stock were reserved and available for issuance under the 2021 Plan, respectively.

	Shares			Weighted-average exercise price		Weighted-average remaining contractual term (years)		Aggregate intrinsic value
Outstanding as of December 31, 2023		17,503,253		$	1.04		7.37	$	42,527
Granted		245,500			0.20
Exercised		-			-				-
Cancelled/forfeited		(631,354	)	$	1.32
Outstanding as of March 31, 2024		17,117,399		$	1.02		7.11	$	104,727
Vested and expected to vest at March 31, 2024		17,117,399		$	1.02		7.11	$	104,727
Vested and exercisable at March 31, 2024		9,205,674		$	0.96		5.68	$	104,727

The following table summarizes information about the Company’s RSUs as of March 31, 2024, and activity during the three months then ended:

	Shares			Weighted- average grant date fair value
Unvested Shares at December 31, 2023		177,294		$	2.80
RSUs granted		-			-
RSUs vested		(12,228	)		5.52
RSUs forfeited		-			-
Unvested Shares at March 31, 2024		165,066		$	2.60

The weighted average per share grant-date fair value of options granted during the three months ended March 31, 2024 and 2023 was $0.11 and $0.57, respectively.

The following weighted average assumptions were used in estimating the grant date fair values for the three months ended March 31, 2024 and 2023:

	March 31,
	2024			2023
Fair value of common stock	$	0.20		$	1.06
Expected term (in years)		6.01			6.03
Risk-free rate		4.10	%		3.73	%
Expected volatility		53.06	%		52.50	%
Dividend yield		0	%		0	%

For the three months ended March 31, 2024 and 2023, the Company recorded stock-based compensation expense from stock options and RSUs of approximately $654,000 and $925,000, respectively.

Retirement Savings Plan

3 Months Ended

Mar. 31, 2024

Retirement Savings Plan [Abstract]

Retirement Savings Plan

10. Retirement Savings Plan

Income Taxes

3 Months Ended

Mar. 31, 2024

Income Taxes [Abstract]

Income Taxes

11. Income Taxes

For the three months ended March 31, 2024 and 2023, the Company recorded income tax expense of $0. The effective tax rate is 0% for the three months ended March 31, 2024 and 2023.

Currently, the Company is not under examination by any taxing authority.

Commitments and Contingencies

3 Months Ended

Mar. 31, 2024

Commitments and Contingencies [Abstract]

Commitments and Contingencies

12. Commitments and Contingencies

Legal Proceedings

Nasdaq Compliance

Risks and Uncertainties

3 Months Ended

Mar. 31, 2024

Risks and Uncertainties [Abstract]

Risks and Uncertainties

13. Risks and Uncertainties

The Company’s business operations, operating results, and financial condition are vulnerable to certain risks and uncertainties including:

●

Inflation and its related impact on costs and expenditures on domestic and foreign-sourced materials and services;

●

Effects of the Russia-Ukraine and Israeli-Palestine conflicts such as possible cyberattacks and potential disruptions in the banking systems and capital markets and the supply chain; and

●

Other factors beyond its control such as natural disasters, terrorism, civil unrest, infectious diseases and pandemics including COVID-19 and its variants.

Subsequent Events

3 Months Ended

Mar. 31, 2024

Subsequent Events [Abstract]

Subsequent Events

14. Subsequent Events

ATM

As of May 8, 2024, the Company has sold 931,910 additional shares under the ATM Sales Agreement, for net proceeds of $141,320 after payment of commission and fees of $2,884.

Common Stock Offering

On May 3, the Company closed on the sale of an additional 2,040,000 shares of common stock, upon exercise by the underwriter of the over-allotment option.

Israeli Entity

As of May 8, 2024, the Company is in the process of creating a wholly-owned entity in Israel for continued research and development efforts.

Pay vs Performance Disclosure - USD ($)	3 Months Ended
Pay vs Performance Disclosure - USD ($)	Mar. 31, 2024	Mar. 31, 2023
Pay vs Performance Disclosure
Net Income (Loss)	$ (5,970,079)	$ (5,628,758)

Insider Trading Arrangements	3 Months Ended
Insider Trading Arrangements	Mar. 31, 2024
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Accounting Policies, by Policy (Policies)

3 Months Ended

Mar. 31, 2024

Summary of Significant Accounting Policies [Abstract]

Basis of Presentation

Basis of Presentation

Principles of Consolidation

Principles of Consolidation

Foreign Currency Translation

Foreign Currency Translation

Use of Estimates

Use of Estimates

Concentration of Credit Risk

Concentration of Credit Risk

Concentration of Supplier Risk

Concentration of Supplier Risk

Cash and Short-term Investments

Cash and Short-term Investments

Accounts Receivable

Accounts Receivable

Fair Value Measurements

Fair Value Measurements

The Company uses the following fair value hierarchy prescribed by U.S. GAAP, which prioritizes the inputs used to measure fair value as follows:

Level 1—Unadjusted quoted prices in active markets for identical assets or liabilities.

Level 3—Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

Property and Equipment

Property and Equipment

Property and Equipment		Useful life
Internal-use software		3 to 5 years
Computer and equipment		5 years
Furniture and fixtures		7 years
Leasehold improvements		Shorter of 3 years or lease term
Vehicles		5 years

Leases

Leases

Costs to Develop Software

Costs to Develop Software

The Company incurs costs related to internally developed software. Based on the nature of the software, the Company capitalizes software costs under the following guidance.

Internal-Use Software costs

Internal-Use Software costs

Costs to Develop Software to be Sold, Leased or Otherwise Marketed

Costs to Develop Software to be Sold, Leased or Otherwise Marketed

The Company accounts for research costs of computer software to be sold, leased or otherwise marketed as expense until technological feasibility has been established for the product. Once technological feasibility is established, certain payroll and stock compensation, occupancy, and professional service costs that are incurred to develop functionality for the Company’s software and internally built software platforms, as well as certain upgrades and enhancements that are expected to result in enhanced functionality are capitalized. Judgment is required in determining when technological feasibility of a product is established. Management has determined that technological feasibility is established when a working model is complete.

Long-Lived Assets and Finite Lived Intangibles

Long-Lived Assets and Finite Lived Intangibles

Income Taxes

Income Taxes

Common Stock Warrants

Common Stock Warrants

Stock-based Compensation

Stock-based Compensation

Net Loss Per Share Attributable to Common Stockholders

Net Loss Per Share Attributable to Common Stockholders

Research and Development Expense

Research and Development Expense

Selling, General, and Administrative Expense

Selling, General, and Administrative Expense

Commitments

Commitments

Segment Reporting

Segment Reporting

Revenue Recognition

Revenue Recognition

Under ASC 606, “Revenue from Contracts with Customers”, the Company determines revenue recognition through the following steps:

●

Identifying the contract, or contracts, with the customer;

●

Identifying the performance obligations in the contract;

●

Determining the transaction price;

●

Allocating the transaction price to performance obligations in the contract; and

●

Recognizing revenue when, or as, the Company satisfies performance obligations by transferring the promised goods or services.

Subscription

For the three months ended March 31, 2024 and 2023, subscription revenue was $2,727 and $1,537, respectively.

Non-Recurring Engineering (“NRE”)

For the three months ended March 31, 2024 and 2023, NRE revenue was $0 and $870,000, respectively.

Hardware

For the three months ended March 31, 2024 and 2023, hardware revenue was $2,786 and $963, respectively.

Other:

For the three months ended March 31, 2024 and 2023, other revenue was $0 and $300, respectively.

Arrangements with Multiple Performance Obligations

Material Rights:

Other Policies, Judgments and Practical Expedients

elected the optional exemption, which allows for the exclusion of the amounts for remaining performance obligations that are part of contracts with an original expected duration of one year or less.

Principal vs. Agent Considerations

Concentration of Credit Risk

The following table sets forth the percentages of total revenue for customers that represents 10% or more of the respective amounts for the three months ended March 31, 2024 and 2023, respectively.

	2024			2023
Customer A		*			76.8	%
Customer B		100	%		*

Below 10%

There were no accounts receivable from these customers at March 31, 2024 and December 31, 2023.

Cost of Revenue

Cost of Revenue

Cost of revenue consists primarily of direct labor and related fringe benefits for internal engineering resources costs incurred for the completion of the contracts and hardware costs.

Summary of Significant Accounting Policies (Tables)

3 Months Ended

Mar. 31, 2024

Summary of Significant Accounting Policies [Abstract]

Schedule of Property and Equipment Estimated Useful Life

Repair and maintenance costs are expensed as incurred.

Property and Equipment		Useful life
Internal-use software		3 to 5 years
Computer and equipment		5 years
Furniture and fixtures		7 years
Leasehold improvements		Shorter of 3 years or lease term
Vehicles		5 years

Schedule of Percentages of Total Revenue

The following table sets forth the percentages of total revenue for customers that represents 10% or more of the respective amounts for the three months ended March 31, 2024 and 2023, respectively.

	2024			2023
Customer A		*			76.8	%
Customer B		100	%		*

Below 10%

Balance Sheet Components (Tables)

3 Months Ended

Mar. 31, 2024

Balance Sheet Components [Abstract]

Schedule of Prepaid Expenses and Other Current Assets

Prepaid expenses and other current assets are comprised of the following:

	March 31, 2024		December 31, 2023
Inventory, net	$	70,280	$	-
Prepaid expenses		437,906		385,474
Security deposits		175,191		155,729
Tax receivables		763,624		765,697
Receivables and current assets		55,114		9,526
Total prepaid and expenses and other current assets	$	1,502,115	$	1,316,426

Schedule of Property and Equipment

Property and equipment is comprised of the following:

	March 31,			December 31,
	2024			2023
Automobiles	$	656,997		$	616,947
Furniture and fixtures		178,491			178,491
Computer and equipment		529,541			517,181
Capitalized software		444,115			342,136
Leasehold improvements		208,848			458,406
Construction work in progress		518,255			208,848
Property and equipment, gross		2,536,247			2,322,009
Less: accumulated depreciation		(883,865	)		(835,337	)
Total property and equipment, net	$	1,652,382		$	1,486,672

Schedule of Accrued Expenses and Other Current Liabilities

Accrued expenses and other current liabilities are comprised of the following:

	March 31, 2024		December 31, 2023
Credit card payable	$	4,699	$	1,103
Accrued expenses		355,910		214,286
Accrued payroll		359,630		985,753
Total accrued expenses and other current liabilities	$	720,239	$	1,201,142

Operating Leases (Tables)

3 Months Ended

Mar. 31, 2024

Operating Leases [Abstract]

Schedule of Future Lease Payments under Non-Cancellable Leases

Period	Operating Lease
Remainder of 2024	$	553,636
2025		320,526
Total lease payments		874,162
Less: imputed interest		(21,936	)
Present value of lease liability	$	852,226

	March 31,			December 31,
	2024			2023
Weighted-average remaining lease term (in years)		1.17			1.42
Weighted -average discount rate		3.60	%		3.05	%

Intangible Assets, Net (Tables)

3 Months Ended

Mar. 31, 2024

Intangible Assets, Net [Abstract]

Schedule of Gross Carrying Amount and Accumulated Amortization

The gross carrying amount and accumulated amortization of separately identifiable intangible assets are as follows:

	As of March 31, 2024
	Gross Carrying Amount		Accumulated Amortization			Impairment			Net Carrying Amount
Developed software	$	542,692	$	-		$	-		$	542,692
Patents		559,474		(25,281	)		(52,723	)		481,470
Trademark		45,000		(23,750	)		-			21,250
Total intangible assets	$	1,147,166	$	(49,031	)	$	(52,723	)	$	1,045,412

	As of December 31, 2023
	Gross Carrying Amount		Accumulated Amortization			Fair Market Value Adjustment			Impairment			Net Carrying Amount
Developed software	$	542,692	$	-		$	-		$	-		$	542,692
Patents		539,840		(20,117	)		-			-			519,723
Trademark		45,000		(23,000	)		-			-			22,000
Rights to intellectual property		100,000		(20,000	)		(50,000	)		(30,000	)		-
Total intangible assets	$	1,227,532	$	(63,117	)	$	(50,000	)	$	(30,000	)	$	1,084,415

Schedule of Estimated Amortization Expense for All Intangible Assets

Estimated amortization expense for all intangible assets subject to amortization in future years is expected to be:

	Amortization
Remainder 2024	$	17,740
2025		23,654
2026		23,654
2027		23,654
2028		23,654
Thereafter		933,056
Total	$	1,045,412

Capital Structure (Tables)

3 Months Ended

Mar. 31, 2024

Capital Structure [Abstract]

Schedule of Securities Warrants are Convertible

Securities into which warrants are convertible	Warrants outstanding		Exercise Price		Expiration Date	Fair value
Common stock (Initial Public Offering)		140,000	$	9.375	October 2026	$	170,397
Common stock (Private Placement)		7,096,776	$	2.71	April 2027		6,745,681
Total		7,236,776				$	6,916,078

Schedule of Fair Value of Warrants

The Company used the following assumptions:

	Initial Public Offering Warrants			Private Placement Warrants
Fair value of underlying securities	$	2.88		$	1.37
Expected volatility		51.0	%		45.0	%
Expected term (in years)		5.0			5.0
Risk-free interest rate		1.13	%		2.92	%

Net Loss Per Share Attributable to Common Stockholders (Tables)

3 Months Ended

Mar. 31, 2024

Net Loss Per Share Attributable to Common Stockholders [Abstract]

Schedule of Basic and Diluted Loss Per Share

The following table summarizes the computation of basic and diluted loss per share:

	Three months Ended March 31,
	2024			2023
Net loss attributable to common stockholders	$	(5,970,079	)	$	(5,628,758	)

Basic and diluted weighted average common shares outstanding		77,081,105			37,685,413

Loss per share:
Basic and diluted	$	(0.08	)	$	(0.15	)

Stock-Based Compensation Expense (Tables)

3 Months Ended

Mar. 31, 2024

Stock-Based Compensation Expense [Abstract]

Schedule of Stock Options Vested and Exercisable

	Shares			Weighted-average exercise price		Weighted-average remaining contractual term (years)		Aggregate intrinsic value
Outstanding as of December 31, 2023		17,503,253		$	1.04		7.37	$	42,527
Granted		245,500			0.20
Exercised		-			-				-
Cancelled/forfeited		(631,354	)	$	1.32
Outstanding as of March 31, 2024		17,117,399		$	1.02		7.11	$	104,727
Vested and expected to vest at March 31, 2024		17,117,399		$	1.02		7.11	$	104,727
Vested and exercisable at March 31, 2024		9,205,674		$	0.96		5.68	$	104,727

Schedule of Restricted Stock Units and Activity

The following table summarizes information about the Company’s RSUs as of March 31, 2024, and activity during the three months then ended:

	Shares			Weighted- average grant date fair value
Unvested Shares at December 31, 2023		177,294		$	2.80
RSUs granted		-			-
RSUs vested		(12,228	)		5.52
RSUs forfeited		-			-
Unvested Shares at March 31, 2024		165,066		$	2.60

Schedule of Weighted Average Assumptions were Used in Estimating the Grant Date Fair Values

The following weighted average assumptions were used in estimating the grant date fair values for the three months ended March 31, 2024 and 2023:

	March 31,
	2024			2023
Fair value of common stock	$	0.20		$	1.06
Expected term (in years)		6.01			6.03
Risk-free rate		4.10	%		3.73	%
Expected volatility		53.06	%		52.50	%
Dividend yield		0	%		0	%

Description of Business (Details) - USD ($)	3 Months Ended
Description of Business (Details) - USD ($)	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Description of Business (Details) [Line Items]
Net loss	$ (5,970,079)	$ (5,628,758)
Accumulated deficit	(165,987,698)		$ (160,017,619)
Net cash used in operating activities	(5,840,394)	(5,377,448)
Unrestricted cash balance	2,192,398		3,591,623
Short-term investments balance	2,578,882		$ 4,561,928
Maximum [Member]
Description of Business (Details) [Line Items]
Net loss	$ (6,000,000)
Minimum [Member]
Description of Business (Details) [Line Items]
Net loss		$ (5,600,000)

Summary of Significant Accounting Policies (Details)			3 Months Ended		12 Months Ended
Summary of Significant Accounting Policies (Details)	Dec. 31, 2023 USD ($)	Apr. 01, 2022 USD ($)	Mar. 31, 2024 USD ($) shares	Mar. 31, 2023 USD ($)	Dec. 31, 2023 USD ($)
Summary of Significant Accounting Policies [Line Items]
Cash	$ 3,591,623		$ 2,192,398		$ 3,591,623
Finite lived intangibles amortized			15 years
Purchase price of rights		$ 100,000
Useful life for intangible asset		15 years
Impairment charge			$ 52,713		$ 30,000
Common warrants (in Shares) \| shares			7,096,776
Advertising Expense			$ 91,099	$ 23,814
Revenue			5,513	872,800
Other revenue			0	300
Right to intellectual property [Member]
Summary of Significant Accounting Policies [Line Items]
Impairment charge	$ 30,000
Subscription [Member]
Summary of Significant Accounting Policies [Line Items]
Revenue			2,727	1,537
Non-Recurring Engineering [Member]
Summary of Significant Accounting Policies [Line Items]
Revenue			0	870,000
Hardware [Member]
Summary of Significant Accounting Policies [Line Items]
Revenue			$ 2,786	$ 963
Minimum [Member]
Summary of Significant Accounting Policies [Line Items]
Useful life of property and equipment			3 years
Cost of revenue			3 years
Maximum [Member]
Summary of Significant Accounting Policies [Line Items]
Useful life of property and equipment			5 years
Cost of revenue			5 years
Chief Executive Officer [Member]
Summary of Significant Accounting Policies [Line Items]
Operating segment					1
IPO [Member]
Summary of Significant Accounting Policies [Line Items]
Common warrants (in Shares) \| shares			140,000

Schedule of Property and Equipment Estimated Useful Life (Details) - Schedule of Property and Equipment Estimated Useful Life	Mar. 31, 2024
Computer and Equipment [Member]
Schedule of Property and Equipment Estimated Useful Life (Details) - Schedule of Property and Equipment Estimated Useful Life [Line Items]
Property, Plant and Equipment, Useful Life	5 years
Furniture and Fixtures [Member]
Schedule of Property and Equipment Estimated Useful Life (Details) - Schedule of Property and Equipment Estimated Useful Life [Line Items]
Property, Plant and Equipment, Useful Life	7 years
Leasehold Improvements [Member]
Schedule of Property and Equipment Estimated Useful Life (Details) - Schedule of Property and Equipment Estimated Useful Life [Line Items]
Property, Plant and Equipment, Useful Life	3 years
Vehicles [Member]
Schedule of Property and Equipment Estimated Useful Life (Details) - Schedule of Property and Equipment Estimated Useful Life [Line Items]
Property, Plant and Equipment, Useful Life	5 years
Minimum [Member] \| Software Development [Member]
Schedule of Property and Equipment Estimated Useful Life (Details) - Schedule of Property and Equipment Estimated Useful Life [Line Items]
Property, Plant and Equipment, Useful Life	3 years
Maximum [Member] \| Software Development [Member]
Schedule of Property and Equipment Estimated Useful Life (Details) - Schedule of Property and Equipment Estimated Useful Life [Line Items]
Property, Plant and Equipment, Useful Life	5 years

Summary of Significant Accounting Policies (Details) - Schedule of Percentages of Total Revenue - Customer Concentration Risk [Member] - Revenue Benchmark [Member]

3 Months Ended

Mar. 31, 2024

Mar. 31, 2023

Customer A [Member]

Disaggregation of Revenue [Line Items]

Customer percentages of total revenue

^[1]

76.80%

Customer B [Member]

Disaggregation of Revenue [Line Items]

Customer percentages of total revenue

100.00%

^[1]

[1]

Below 10%

Revenue and Contracts with Customers (Details) - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Revenue and Contracts with Customers [Abstract]
Contract liabilities
Contract assets
Deferred contract costs	$ 0	$ 0

Balance Sheet Components (Details) - USD ($)	3 Months Ended
Balance Sheet Components (Details) - USD ($)	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Balance Sheet Components [Abstract]
Treasury bills	$ 2,600,000		$ 4,600,000
Depreciation expense	48,528	$ 81,464
Accounts payable	$ 42,500		$ 41,250

Balance Sheet Components (Details) - Schedule of Prepaid Expenses and Other Current Assets - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Schedule of Prepaid Expenses and Other Current Assets [Abstract]
Inventory, net	$ 70,280
Prepaid expenses	437,906	385,474
Security deposits	175,191	155,729
Tax receivables	763,624	765,697
Receivables and current assets	55,114	9,526
Total prepaid and expenses and other current assets	$ 1,502,115	$ 1,316,426

Balance Sheet Components (Details) - Schedule of Property and Equipment - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Schedule of Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 2,536,247	$ 2,322,009
Less: accumulated depreciation and amortization	(883,865)	(835,337)
Total property and equipment, net	1,652,382	1,486,672
Vehicles [Member]
Schedule of Property, Plant and Equipment [Line Items]
Property and equipment, gross	656,997	616,947
Furniture and fixtures [Member]
Schedule of Property, Plant and Equipment [Line Items]
Property and equipment, gross	178,491	178,491
Computer and equipment [Member]
Schedule of Property, Plant and Equipment [Line Items]
Property and equipment, gross	529,541	517,181
Capitalized software [Member]
Schedule of Property, Plant and Equipment [Line Items]
Property and equipment, gross	444,115	342,136
Leasehold improvements [Member]
Schedule of Property, Plant and Equipment [Line Items]
Property and equipment, gross	208,848	458,406
Construction work in progress [Member]
Schedule of Property, Plant and Equipment [Line Items]
Property and equipment, gross	$ 518,255	$ 208,848

Balance Sheet Components (Details) - Schedule of Accrued Expenses and Other Current Liabilities - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Schedule Of Accrued Expenses And Other Current Liabilities [Abstract]
Credit card payable	$ 4,699	$ 1,103
Accrued expenses	355,910	214,286
Accrued payroll	359,630	985,753
Total accrued expenses and other current liabilities	$ 720,239	$ 1,201,142

Operating Leases (Details) - USD ($)	3 Months Ended
Operating Leases (Details) - USD ($)	Mar. 31, 2024	Mar. 31, 2023
Operating Leases [Abstract]
Monthly payments	$ 60,000
Lease expense	180,660	$ 142,586
Operating lease right-of-use assets	$ 171,148	$ 138,020

Operating Leases (Details) - Schedule of Future Lease Payments under Non-Cancellable Lease - USD ($)	Mar. 31, 2024	Dec. 31, 2023
Schedule of Future Lease Payments Under Non Cancellable Leases [Abstract]
2024	$ 553,636
2025	320,526
Total lease payments	874,162
Less: imputed interest	(21,936)
Present value of lease liability	$ 852,226
Weighted-average remaining lease term (in years)	1 year 2 months 1 day	1 year 5 months 1 day
Weighted -average discount rate	3.60%	3.05%

Intangible Assets, Net (Details) - USD ($)	3 Months Ended		12 Months Ended
Intangible Assets, Net (Details) - USD ($)	Mar. 31, 2024	Mar. 31, 2023	Dec. 31, 2023
Intangible Assets, Net [Line Items]
Amortization expense	$ 5,914	$ 8,547
Gain (loss) on disposal assets	(52,723)
Salvage value	0
Impair inventory	0
Fair market value adjustment			(50,000)
Impairment charge	52,713		$ 30,000
Abandoned Inventory [Member]
Intangible Assets, Net [Line Items]
Inventory loss	$ 66,690

Intangible Assets, Net (Details) - Schedule of Gross Carrying Amount and Accumulated Amortization - USD ($)	3 Months Ended	12 Months Ended
	Mar. 31, 2024	Dec. 31, 2023
Gross Carrying Amount [Member]
Schedule of Gross Carrying Amount and Accumulated Amortization [Line Items]
Gross Carrying Amount	$ 1,147,166	$ 1,227,532
Gross Carrying Amount [Member] \| Developed software [Member]
Schedule of Gross Carrying Amount and Accumulated Amortization [Line Items]
Gross Carrying Amount	542,692	542,692
Gross Carrying Amount [Member] \| Patents [Member]
Schedule of Gross Carrying Amount and Accumulated Amortization [Line Items]
Gross Carrying Amount	559,474	539,840
Gross Carrying Amount [Member] \| Trademark [Member]
Schedule of Gross Carrying Amount and Accumulated Amortization [Line Items]
Gross Carrying Amount	45,000	45,000
Gross Carrying Amount [Member] \| Rights to intellectual property [Member]
Schedule of Gross Carrying Amount and Accumulated Amortization [Line Items]
Gross Carrying Amount		100,000
Accumulated Amortization [Member]
Schedule of Gross Carrying Amount and Accumulated Amortization [Line Items]
Accumulated Amortization	(49,031)	(63,117)
Accumulated Amortization [Member] \| Developed software [Member]
Schedule of Gross Carrying Amount and Accumulated Amortization [Line Items]
Accumulated Amortization
Accumulated Amortization [Member] \| Patents [Member]
Schedule of Gross Carrying Amount and Accumulated Amortization [Line Items]
Accumulated Amortization	(25,281)	(20,117)
Accumulated Amortization [Member] \| Trademark [Member]
Schedule of Gross Carrying Amount and Accumulated Amortization [Line Items]
Accumulated Amortization	(23,750)	(23,000)
Accumulated Amortization [Member] \| Rights to intellectual property [Member]
Schedule of Gross Carrying Amount and Accumulated Amortization [Line Items]
Accumulated Amortization		(20,000)
Impairment [Member]
Schedule of Gross Carrying Amount and Accumulated Amortization [Line Items]
Impairment	(52,723)	(30,000)
Impairment [Member] \| Developed software [Member]
Schedule of Gross Carrying Amount and Accumulated Amortization [Line Items]
Impairment
Impairment [Member] \| Patents [Member]
Schedule of Gross Carrying Amount and Accumulated Amortization [Line Items]
Impairment	(52,723)
Impairment [Member] \| Trademark [Member]
Schedule of Gross Carrying Amount and Accumulated Amortization [Line Items]
Impairment
Impairment [Member] \| Rights to intellectual property [Member]
Schedule of Gross Carrying Amount and Accumulated Amortization [Line Items]
Impairment		(30,000)
Net Carrying Amount [Member]
Schedule of Gross Carrying Amount and Accumulated Amortization [Line Items]
Net Carrying Amount	1,045,412	1,084,415
Net Carrying Amount [Member] \| Developed software [Member]
Schedule of Gross Carrying Amount and Accumulated Amortization [Line Items]
Net Carrying Amount	542,692	542,692
Net Carrying Amount [Member] \| Patents [Member]
Schedule of Gross Carrying Amount and Accumulated Amortization [Line Items]
Net Carrying Amount	481,470	519,723
Net Carrying Amount [Member] \| Trademark [Member]
Schedule of Gross Carrying Amount and Accumulated Amortization [Line Items]
Net Carrying Amount	$ 21,250	22,000
Net Carrying Amount [Member] \| Rights to intellectual property [Member]
Schedule of Gross Carrying Amount and Accumulated Amortization [Line Items]
Net Carrying Amount
Fair value market adjustment [Member]
Schedule of Gross Carrying Amount and Accumulated Amortization [Line Items]
Fair Market Value Adjustment		(50,000)
Fair value market adjustment [Member] \| Developed software [Member]
Schedule of Gross Carrying Amount and Accumulated Amortization [Line Items]
Fair Market Value Adjustment
Fair value market adjustment [Member] \| Patents [Member]
Schedule of Gross Carrying Amount and Accumulated Amortization [Line Items]
Fair Market Value Adjustment
Fair value market adjustment [Member] \| Trademark [Member]
Schedule of Gross Carrying Amount and Accumulated Amortization [Line Items]
Fair Market Value Adjustment
Fair value market adjustment [Member] \| Rights to intellectual property [Member]
Schedule of Gross Carrying Amount and Accumulated Amortization [Line Items]
Fair Market Value Adjustment		$ (50,000)

Intangible Assets, Net (Details) - Schedule of Estimated Amortization Expense for All Intangible Assets	Mar. 31, 2024 USD ($)
Schedule of Estimated Amortization Expense for All Intangible Assets [Abstract]
2024	$ 17,740
2025	23,654
2026	23,654
2027	23,654
2028	23,654
Thereafter	933,056
Total	$ 1,045,412

Capital Structure (Details) - USD ($)			1 Months Ended	3 Months Ended	12 Months Ended
Capital Structure (Details) - USD ($)	May 31, 2023	Jan. 29, 2023	May 31, 2022	Mar. 31, 2024	Dec. 31, 2023	Dec. 08, 2023	Oct. 31, 2021
Capital Structure [Line Items]
Common stock, shares authorized				200,000,000	200,000,000
Common stock, par value (in Dollars per share)				$ 0.00001	$ 0.00001
Common stock, shares issued				88,454,654	64,773,756
Common stock, shares outstanding				88,454,654	64,773,756
Convertible preferred stock, shares authorized				10,000,000	10,000,000
Preferred stock, par value (in Dollars per share)				$ 0.00001	$ 0.00001
Preferred stock issued
Preferred stock outstanding
Aggregate shares						33,333,333
Warrant purchase						21,866,600
Warrant exercise price per share (in Dollars per share)				$ 2.98		$ 0.00001
Common warrant offering price (in Dollars per share)				$ 3.09		0.15
Gross proceeds (in Dollars)		$ 20,000,000		$ 5,000,000
Other direct costs (in Dollars)				500,000
Sale of common stock (in Dollars)				884	$ 648
Percentage of gross proceeds	3.00%
Net proceeds (in Dollars)				4,460,639
Commission fees (in Dollars)				91,033
Other expenses (in Dollars)				$ 60,465
Common stock				3,790,322
Pre-Funded warrant exercisable				2,661,291
Common warrants				6,451,613
Warrants outstanding				7,096,776
Exercise price (in Dollars per share)					$ 2.71
Pre-Funded Warrants [Member]
Capital Structure [Line Items]
Common warrant offering price (in Dollars per share)						$ 0.14999
Exercise price per share (in Dollars per share)			$ 0.001
Common Stock [Member]
Capital Structure [Line Items]
Common stock, shares authorized				200,000,000
Common stock, shares issued				88,454,654	64,773,756	11,466,733
Common stock, shares outstanding				88,454,654	64,773,756
Shares of common stock				17,034,205
Convertible Preferred Stock [Member]
Capital Structure [Line Items]
Convertible preferred stock, shares authorized							10,000,000
Preferred stock, par value (in Dollars per share)							$ 0.00001
Preferred Stock Issued [Member]
Capital Structure [Line Items]
Preferred stock issued
Preferred Stock Outstanding [Member]
Capital Structure [Line Items]
Preferred stock outstanding
ATM Sales Agreement [Member]
Capital Structure [Line Items]
Sale of common stock (in Dollars)	$ 8,800,000
Purchase Warrants [Member]
Capital Structure [Line Items]
Common stock				3,790,322
Pre-Funded warrant exercisable				2,661,291
Private Placement [Member]
Capital Structure [Line Items]
Common warrant offering price (in Dollars per share)				$ 3.1

Capital Structure (Details) - Schedule of Securities Warrants are Convertible - Warrant [Member]	3 Months Ended
	Mar. 31, 2024 USD ($) $ / shares shares
Schedule of Securities Warrants are Convertible [Line Items]
Warrants outstanding \| shares	7,236,776
Fair value \| $	$ 6,916,078
Initial Public Offering [Member] \| Common Stock [Member]
Schedule of Securities Warrants are Convertible [Line Items]
Warrants outstanding \| shares	140,000
Exercise Price \| $ / shares	$ 9.375
Expiration Date	October 2026
Fair value \| $	$ 170,397
Private Placement [Member] \| Common Stock [Member]
Schedule of Securities Warrants are Convertible [Line Items]
Warrants outstanding \| shares	7,096,776
Exercise Price \| $ / shares	$ 2.71
Expiration Date	April 2027
Fair value \| $	$ 6,745,681

Capital Structure (Details) - Schedule of Fair Value of Warrants	3 Months Ended
	Mar. 31, 2024 $ / shares
Initial Public Offering Warrants [Member]
Schedule of Fair Value of Warrants [Line Items]
Fair value of underlying securities (in Dollars per share)	$ 2.88
Expected volatility	51.00%
Expected term (in years)	5 years
Risk-free interest rate	1.13%
Private Placement Warrants [Member]
Schedule of Fair Value of Warrants [Line Items]
Fair value of underlying securities (in Dollars per share)	$ 1.37
Expected volatility	45.00%
Expected term (in years)	5 years
Risk-free interest rate	2.92%

Net Loss Per Share Attributable to Common Stockholders (Details)	Oct. 30, 2023
Net Loss Per Share Attributable to Common Stockholders [Abstract]
Stock dividend	10.00%

Net Loss Per Share Attributable to Common Stockholders (Details) - Schedule of Basic and Diluted Loss Per Share - USD ($)	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Schedule of Basic and Diluted Loss Per Share [Abstract]
Net loss attributable to common stockholders	$ (5,970,079)	$ (5,628,758)
Basic weighted average common shares outstanding	77,081,105	37,685,413
Loss per share:
Basic loss per share	$ (0.08)	$ (0.15)

Net Loss Per Share Attributable to Common Stockholders (Details) - Schedule of Basic and Diluted Loss Per Share (Parentheticals) - $ / shares	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Schedule of Basic and Diluted Loss Per Share [Abstract]
Diluted weighted average common shares outstanding	77,081,105	37,685,413
Diluted loss per share	$ (0.08)	$ (0.15)

Stock-Based Compensation Expense (Details) - USD ($)		3 Months Ended	12 Months Ended
Stock-Based Compensation Expense (Details) - USD ($)	Nov. 07, 2023	Mar. 31, 2024	Dec. 31, 2023
Stock-Based Compensation Expense [Line Items]
Stock option term, description		The resulting fair value is recognized on a straight-line basis over the period during which an employee is required to provide service in exchange for the award. The Company has elected to recognize forfeitures as they occur. Stock options generally vest over four years and have a contractual term of ten years.
Number of shares authorized	5,000,000
Percentage of outstanding common stock	5.00%
Shares of common stock	2,500,000	8,600,000	700,000
Weighted average per share (in Dollars per share)		$ 0.11	$ 0.57
Stock-based compensation expense (in Dollars)		$ 654,000	$ 925,000
Outstanding unvested stock options (in Dollars)		$ 5,700,000
Weighted-average period		2 years 7 months 6 days

Stock-Based Compensation Expense (Details) - Schedule of Stock Options Vested and Exercisable - USD ($)		3 Months Ended
	Dec. 31, 2023	Mar. 31, 2024
Schedule of Stock Options Vested and Exercisable [Abstract]
Shares, granted		245,500
Weighted- average exercise price, granted		$ 0.2
Shares, exercised
Weighted-average exercise price, exercised
Shares, cancelled/forfeited		(631,354)
Weighted-average exercise price, cancelled/forfeited		$ 1.32
Shares, outstanding at Ending balance	17,503,253	17,117,399
Weighted-average exercise price, outstanding at Ending balance	$ 1.04	$ 1.02
Weighted-average remaining contractual term (years), outstanding at Ending balance	7 years 4 months 13 days	7 years 1 month 9 days
Aggregate intrinsic value, outstanding at Ending balance	$ 42,527	$ 104,727
Shares, vested and expected to vest at ending balance		17,117,399
Weighted-average exercise price, vested and expected to vest at ending balance		$ 1.02
Weighted-average remaining contractual term (years), vested and expected to vest at ending balance		7 years 1 month 9 days
Aggregate intrinsic value, vested and expected to vest at ending balance		$ 104,727
Shares, vested and exercisable at ending balance		9,205,674
Weighted-average exercise price, vested and exercisable at ending balance		$ 0.96
Weighted-average remaining contractual term (years), vested and exercisable at ending balance		5 years 8 months 4 days
Aggregate intrinsic value, vested and exercisable at ending balance		$ 104,727

Stock-Based Compensation Expense (Details) - Schedule of Restricted Stock Units and Activity - RSUs [Member]	3 Months Ended
	Mar. 31, 2024 $ / shares shares
Schedule of Restricted Stock Units and Activity [Abstract]
Shares, Unvested shares beginning balance \| shares	177,294
Weighted-average grant date fair value, beginning balance \| $ / shares	$ 2.8
Shares, RSUs granted \| shares
Weighted-average grant date fair value, RSUs granted \| $ / shares
Shares, RSUs vested \| shares	(12,228)
Weighted-average grant date fair value, RSUs vested \| $ / shares	$ 5.52
Shares, RSUs forfeited \| shares
Weighted-average grant date fair value, RSUs forfeited \| $ / shares
Shares, Unvested shares ending balance \| shares	165,066
Weighted-average grant date fair value, ending balance \| $ / shares	$ 2.6

Stock-Based Compensation Expense (Details) - Schedule of Weighted Average Assumptions were Used in Estimating the Grant Date Fair Values - $ / shares	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Schedule of Weighted Average Assumptions were Used in Estimating the Grant Date Fair Values [Abstract]
Fair value of common stock (in Dollars per share)	$ 0.2	$ 1.06
Expected term (in years)	6 years 3 days	6 years 10 days
Risk-free rate	4.10%	3.73%
Expected volatility	53.06%	52.50%
Dividend yield	0.00%	0.00%

Income Taxes (Details) - USD ($)	3 Months Ended
Income Taxes (Details) - USD ($)	Mar. 31, 2024	Mar. 31, 2023
Income Taxes [Abstract]
Income tax expense	$ 0	$ 0
Effective tax rate	0.00%	0.00%

Commitments and Contingencies (Details)	Aug. 24, 2023 $ / shares
Nasdaq Compliance [Member]
Commitments and Contingencies [Line Items]
Price of per share	$ 1
Per share of common stock	1
Regain Compliance [Member]
Commitments and Contingencies [Line Items]
Price of per share	$ 1

Subsequent Events (Details) - USD ($)			3 Months Ended
Subsequent Events (Details) - USD ($)	May 08, 2024	Apr. 23, 2024	Mar. 31, 2024	May 03, 2024
Subsequent Events [Line Items]
Additional shares	931,910
Agreement for net proceeds (in Dollars)	$ 141,320
Fees (in Dollars)	$ 2,884
Gross proceeds (in Dollars)			$ 5,200,000
Other direct cost (in Dollars)			$ 600,000
Subsequent Event [Member]
Subsequent Events [Line Items]
Additional shares		19,800,000
Aggregate share		50,000,000
Warrants to purchase		30,200,000
Exercise price (in Dollars per share)		$ 0.00001
Offering price (in Dollars per share)		0.1
Subsequent Event [Member] \| Warrant [Member]
Subsequent Events [Line Items]
Offering price (in Dollars per share)		$ 0.09999
Over-Allotment Option [Member] \| Subsequent Event [Member]
Subsequent Events [Line Items]
Shares of common stock				2,040,000

CYNGN (NASDAQ:CYN)
Gráfico Histórico do Ativo
De Dez 2024 até Jan 2025

CYNGN (NASDAQ:CYN)
Gráfico Histórico do Ativo
De Jan 2024 até Jan 2025

Dados

Notícias

Ferramentas

Mercados

Comunidade

Recursos principais

Follow Feed

Fluxo de Opções

Monitor

CYN CYNGN Inc

Notícias CYNGN Inc

Seu Histórico Recente

Empresa

Negócios

Popular

Obter o aplicativo

Tendências Agora

Rankings

Dados

Notícias

Ferramentas

Mercados

Comunidade

Recursos principais

Follow Feed

Fluxo de Opções

Monitor

CYN CYNGN Inc

Notícias CYNGN Inc

Seu Histórico Recente

Empresa

Negócios

Popular

Obter o aplicativo